Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
21491868	s-kryog	— (—)	1279	1429	100.00%	Distribution not available
21491868	s-kryog	g/l (g/l)	172	244	43.85%
21491868	s-kryopre	— (—)	24	33	100.00%	Distribution not available
21491868	s-kryopre	g/l (g/l)	8	8	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other disorders of skin and subcutaneous tissue

461

685

6.04

249.66

1.3

1.2

0.86

0.31

g/l

1.14

ILD medications: immunosuppressive drugs

393

610

6.04

216.82

1.2

1.1

0.64

0.45

g/l

0.27

Systemic connective tissue disorders

304

403

7.66

215.07

1.2

0.70

0.32

g/l

0.56

Ulcer of lower limb, not elsewhere classified

187

127

15.15

211.29

1.3

1.2

0.56

0.14

g/l

—

ILD medications

564

667

4.61

187.43

1.3

1.1

0.46

0.44

g/l

0.03

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

517

813

4.41

180.81

1.3

1.1

0.56

0.51

g/l

0.08

ILD medications: prednisolone, methylprednisolone, prednisone

529

661

4.50

173.67

1.3

1.1

0.49

0.44

g/l

0.07

Oral corticosteroids

515

769

3.99

150.41

1.3

1.1

0.61

0.41

g/l

0.37

First line medication for Crohn's disease

507

680

4.05

145.00

1.2

1.1

0.48

0.42

g/l

0.10

Inflammatory bowel disease treatment related agents

530

784

3.80

141.85

1.3

1.1

0.49

0.41

g/l

0.15

Other and unspecified dermatitis

312

660

4.77

136.49

1.2

0.57

0.58

g/l

0.01

Other systemic involvement of connective tissue (FG)

197

278

7.09

129.67

1.2

0.30

0.21

g/l

0.25

Autoimmune diseases excluding thyroid diseases

479

682

3.85

129.24

1.2

0.57

0.46

g/l

0.16

Other systemic involvement of connective tissue

204

308

6.71

128.35

1.2

0.30

0.32

g/l

0.04

Autoimmune diseases excluding thyroid diseases, strict definition

463

655

3.89

126.74

1.2

0.52

0.47

g/l

0.06

Coagulation defects, purpura and other haemorrhagic conditions

180

244

7.51

125.13

1.5

1.1

0.75

0.28

g/l

—

Dermatitis

333

793

4.21

124.66

1.2

0.57

0.56

g/l

0.01

Renal failure

260

455

5.10

117.91

1.4

1.2

0.16

0.54

g/l

0.99

Autoimmune diseases related-to ILD

405

970

3.59

116.13

1.2

0.43

0.57

g/l

0.20

All chronic kidney diseases

282

491

4.73

114.31

1.4

1.2

0.22

0.65

g/l

0.90

Fever of other and unknown origin

280

556

4.51

110.53

1.3

1.2

0.75

0.48

g/l

0.30

Diseases of the skin and subcutaneous tissue

391

489

4.03

107.83

1.2

0.34

0.47

g/l

0.23

Chronic kidney disease

186

302

6.10

106.10

1.4

1.2

0.17

0.74

g/l

0.96

Second line medication for Crohn's disease

306

794

3.88

102.55

1.3

1.2

0.61

0.33

g/l

0.54

Other bacterial diseases

411

813

3.41

101.57

1.2

0.28

0.72

g/l

1.18

L04AX Other immunosuppressants

300

774

3.90

101.36

1.3

1.2

0.61

0.34

g/l

0.50

Purpura and other haemorrhagic conditions

133

162

8.38

101.36

1.5

1.2

0.82

0.33

g/l

—

Liquid cancers, helper endpoint

227

399

5.01

100.50

1.4

1.2

1.40

0.18

g/l

2.42

Other bacterial diseases

433

832

3.32

100.50

1.2

0.63

0.48

g/l

0.21

Bacterial infection, other or unspecified

257

499

4.50

100.28

1.2

0.28

0.87

g/l

1.18

Bacterial infection, other or unspecified

272

549

4.22

96.99

1.2

0.37

0.81

g/l

0.80

Diseases of arteries, arterioles and capillaries

317

625

3.77

93.14

1.2

0.45

0.69

g/l

0.30

Glomerular diseases

146

225

6.59

90.25

1.4

1.2

0.29

0.19

g/l

0.35

All kidney diseases

405

904

3.07

85.53

1.3

1.2

0.41

0.63

g/l

0.41

General symptoms and signs

415

652

3.20

83.95

1.2

0.24

0.46

g/l

0.56

Primary_lymphoid and hematopoietic malignant neoplasms

156

278

5.68

83.21

1.5

1.1

1.22

0.16

g/l

2.04

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

14.05

83.04

1.4

1.3

1.56

0.07

g/l

—

Mixed connective tissue disease

11.37

82.58

1.2

1.3

0.16

0.28

g/l

—

Autoimmune diseases

418

684

3.12

81.75

1.2

0.48

0.46

g/l

0.02

Other and unspecified polyneuropathies, also in other diseases

138

230

6.08

78.98

1.5

1.2

0.54

0.17

g/l

0.97

Dermatitis and eczema

438

957

2.85

78.82

1.2

0.52

0.55

g/l

0.03

Polyneuropathies and other disorders of the peripheral nervous system

146

262

5.64

77.35

1.5

1.2

0.48

0.16

g/l

1.03

Tramadol

331

610

3.35

77.27

1.2

0.93

0.43

g/l

0.66

Used for control exclusion in common control thyroid runs

380

623

3.09

73.23

1.2

0.26

0.49

g/l

0.45

Renal tubulo-interstitial diseases

351

892

2.94

70.70

1.3

1.2

0.47

0.63

g/l

0.27

Aplastic and other anaemias

214

519

3.87

70.25

1.3

1.2

0.80

0.23

g/l

1.07

Cardiovascular diseases

235

309

4.10

68.62

1.2

0.10

0.22

g/l

—

Bacterial Sepsis

213

474

3.86

68.06

1.2

0.29

0.75

g/l

0.76

Finngen Rheumatological endpoints

368

723

2.91

66.84

1.2

0.23

0.44

g/l

0.62

Oedema, not elsewhere classified

151

312

4.81

66.81

1.4

1.2

1.20

0.43

g/l

—

Septicaemia

180

404

4.19

66.04

1.3

1.2

0.18

0.58

g/l

0.94

Other specified/unspecified systemic involvement of connective tissue

11.44

65.90

1.2

0.19

0.43

g/l

—

Other and unspecified anaemias

196

485

3.88

65.00

1.3

1.2

0.74

0.24

g/l

0.74

Erysipelas

276

659

3.21

64.86

1.2

0.83

0.57

g/l

0.19

Other anaemias

197

489

3.85

64.76

1.3

1.2

0.74

0.24

g/l

0.73

Dialysis, with operation codes

146

6.89

63.90

1.6

1.2

0.35

0.34

g/l

—

Glomerulonephritis

117

7.75

63.70

1.6

1.2

0.39

0.10

g/l

—

Acute renal failure

123

229

5.43

62.66

1.5

1.2

0.23

0.47

g/l

—

Reimbursement for rheumatic diseases

254

809

3.14

61.82

1.1

1.2

0.47

0.38

g/l

0.13

Nephropathy related operations

144

6.78

61.01

1.5

1.2

0.50

0.33

g/l

—

Other septicaemia

160

364

4.25

60.37

1.3

1.2

0.21

0.61

g/l

0.83

Heart failure, not strict

284

637

3.04

59.01

1.2

0.16

0.83

g/l

1.80

Explicit Sepsis

192

490

3.68

58.86

1.2

0.18

0.53

g/l

0.90

Certain infectious and parasitic diseases

338

587

2.89

58.42

1.2

1.1

0.16

0.52

g/l

0.96

Erysipelas

218

572

3.39

58.19

1.2

0.05

0.75

g/l

—

Implicit bacterial Sepsis

182

424

3.83

58.13

1.2

0.32

0.57

g/l

0.35

Cerebrovascular diseases (FINNGEN)

148

222

4.75

57.35

1.1

0.13

0.30

g/l

—

Other soft tissue disorders, not elsewhere classified

351

764

2.70

56.70

1.2

0.87

0.46

g/l

—

Glomerular disorders in diseases classified elsewhere

131

6.74

55.11

1.2

0.12

0.11

g/l

—

Pain in limb

310

748

2.78

55.02

1.2

1.12

0.47

g/l

0.59

Implicit bacterial Sepsis

189

457

3.59

54.73

1.2

0.32

0.78

g/l

0.67

Cardiovascular diseases (excluding rheumatic etc)

241

428

3.25

52.81

1.2

0.12

0.40

g/l

1.17

Opioids

341

669

2.66

51.38

1.2

0.22

0.41

g/l

0.53

Polyarthropathies

269

609

2.90

50.98

1.2

0.41

0.55

g/l

0.27

Other disorders of skin and subcutaneous tissue, not elsewhere classified

133

6.39

50.67

1.2

1.01

0.11

g/l

—

Urticaria and erythema

171

492

3.50

49.56

1.3

1.2

1.00

0.15

g/l

1.03

L04AA Selective immunosuppressants

130

309

4.25

49.50

1.2

0.19

0.24

g/l

0.24

Infections, IBD-co-morbidities

8.33

47.47

1.3

1.1

0.08

0.17

g/l

—

Headache

224

608

2.95

46.57

1.2

1.09

0.46

g/l

0.70

Diseases of arteries, arterioles and capillaries (FINNGEN)

115

163

4.92

46.01

1.2

1.1

0.49

0.37

g/l

0.11

Hypertensive diseases (excluding secondary)

195

341

3.34

44.69

1.2

0.15

0.42

g/l

0.86

Certain infectious and parasitic diseases

232

394

2.96

41.84

1.2

1.1

0.24

0.18

g/l

0.29

Certain disorders involving the immune mechanism

104

242

4.34

40.79

1.7

1.1

0.87

0.12

g/l

1.17

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

6.89

40.72

1.4

1.2

1.80

0.34

g/l

—

Extracorporeal dialysis

7.62

39.53

1.7

1.1

0.09

0.12

g/l

—

Pain in joint

207

457

2.90

39.16

1.1

1.2

0.70

0.21

g/l

—

Any gastric operation

250

462

2.72

39.13

1.2

0.16

0.27

g/l

0.73

GASTRO-related operations

250

462

2.72

39.13

1.2

0.16

0.27

g/l

0.73

Viral hepatitis

104

6.36

38.94

1.6

1.1

0.33

0.04

g/l

—

Urticaria

135

392

3.47

38.71

1.3

1.2

1.19

0.17

g/l

—

Persons encountering health services in other circumstances, wide

380

897

2.19

38.14

1.2

0.62

0.45

g/l

0.26

Implicit Sepsis

249

758

2.49

36.86

1.3

1.2

0.33

0.74

g/l

0.79

Malaise and fatigue

167

444

3.04

36.68

1.3

1.2

0.64

0.54

g/l

—

Codeine

291

660

2.40

36.68

1.1

1.2

0.21

0.41

g/l

—

Symptoms and signs involving the skin and subcutaneous tissue

249

1024

2.39

35.80

1.3

1.2

0.85

0.52

g/l

—

Heart failure,strict

177

424

2.96

35.78

1.3

1.2

0.26

0.92

g/l

1.18

Other arthritis (FG)

123

355

3.48

35.64

1.3

1.2

0.53

0.20

g/l

—

Neurological diseases, wide definition

5.38

35.38

1.1

1.3

0.06

0.64

g/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

295

778

2.30

34.98

1.3

1.2

0.44

0.65

g/l

0.33

295

778

2.30

34.98

1.3

1.2

0.44

0.65

g/l

0.33

Other heart diseases

162

342

3.10

34.70

1.2

0.14

0.27

g/l

0.72

Hypertensive diseases

265

620

2.42

34.36

1.2

0.15

0.54

g/l

1.49

Hypertension

265

620

2.42

34.34

1.2

0.14

0.54

g/l

1.49

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

313

909

2.21

34.32

1.2

0.25

0.61

g/l

1.17

Implicit Sepsis

262

818

2.35

34.10

1.3

1.2

0.32

0.74

g/l

0.85

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

155

312

3.15

33.62

1.2

0.26

0.43

g/l

—

Other diseases of blood and blood-forming organs, wide

106

290

3.68

33.35

1.3

1.2

0.26

0.22

g/l

—

Enlarged lymph nodes

151

4.87

33.15

1.5

1.1

1.15

0.07

g/l

—

Abnormal findings on examination of blood, without diagnosis

169

558

2.79

33.05

1.5

1.1

1.58

0.30

g/l

1.35

Heart failure and antihypertensive medication

150

4.30

33.03

1.3

1.2

0.13

0.40

g/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

348

896

2.12

32.85

1.2

0.68

0.45

g/l

0.31

Other disorders of veins

157

548

2.86

32.72

1.1

1.2

0.55

0.42

g/l

0.11

Other and unspecified urticaria

245

3.91

32.53

1.3

1.2

1.74

0.14

g/l

—

Exposure to unspecified factor

322

1101

2.11

32.38

1.2

0.63

0.51

g/l

0.09

Condition for Implicit Sepsis (Organ dysfunction codes)

281

869

2.23

32.25

1.2

0.54

0.62

g/l

0.09

Peripheral artery disease

147

387

3.04

32.22

1.2

0.68

0.71

g/l

—

Influenza and pneumonia

334

1019

2.09

31.82

1.3

1.2

0.45

0.60

g/l

0.24

Pneumonias (Asthma/COPD co-morbidities)

317

1014

2.10

31.18

1.3

1.2

0.47

0.60

g/l

0.21

Hypertension, essential

251

603

2.36

31.03

1.2

0.15

0.56

g/l

1.48

All pneumoniae

318

1018

2.09

30.82

1.3

1.2

0.47

0.61

g/l

0.22

Condition for Implicit Sepsis (Organ dysfunction codes)

265

837

2.24

30.80

1.3

1.2

0.29

0.73

g/l

1.06

Examination and observation for other reasons

198

436

2.64

30.75

1.2

1.1

0.72

0.23

g/l

0.63

Atherosclerosis, excluding cerebral and coronary sclerosis

138

362

3.03

30.15

1.2

0.59

0.54

g/l

—

Oxycodone

126

370

3.09

29.51

1.5

1.1

1.03

0.54

g/l

0.38

Infections of the skin and subcutaneous tissue

206

862

2.37

29.46

1.2

0.18

0.49

g/l

1.24

Diseases of the musculoskeletal system and connective tissue

160

272

2.96

29.08

1.2

1.3

0.11

0.64

g/l

—

Unspecified kidney failure

5.76

28.93

1.6

1.2

0.11

0.37

g/l

—

Codeine or tramadol medication

353

969

2.00

28.83

1.2

0.52

0.48

g/l

0.04

Pneumonia, organism unspecified

282

933

2.12

28.76

1.3

1.2

0.50

0.66

g/l

0.25

Heart failure, strict

186

519

2.54

28.39

1.3

1.2

0.27

0.83

g/l

1.05

Soft tissue disorders

312

774

2.08

27.91

1.2

0.32

0.46

g/l

0.31

Disturbances of skin sensation

114

367

3.12

27.82

1.5

1.2

1.06

0.20

g/l

—

Other specific joint derangements/joint disorders

235

670

2.27

27.70

1.1

1.2

0.18

0.53

g/l

—

Other specified/unspecified arthritis

108

338

3.21

27.63

1.3

1.2

0.61

0.21

g/l

—

STROKE

186

505

2.51

27.59

1.1

1.2

0.26

0.85

g/l

—

Antihypertensive medication - note that there are other indications

191

400

2.54

26.92

1.2

0.13

0.41

g/l

—

Complications of surgical and medical care, not elsewhere classified

305

1044

2.00

26.64

1.3

1.2

0.63

0.52

g/l

0.15

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

300

1021

2.01

26.30

1.3

1.2

0.50

0.59

g/l

0.15

Dyspnoea

277

1002

2.05

26.05

1.3

1.2

0.46

0.59

g/l

0.19

Implicit viral Sepsis

108

351

3.09

25.95

1.2

0.41

0.37

g/l

—

Venous thromboembolism

177

720

2.38

25.47

1.3

1.2

0.55

0.52

g/l

—

Non-Hodgkin lymphoma, all, including Hilmo

148

4.36

25.45

1.6

1.2

1.36

0.09

g/l

—

Covid-19 confirmed case

129

468

2.77

25.44

1.1

1.2

0.60

0.27

g/l

—

Asthma, excluding more controls

219

497

2.30

25.13

1.2

1.58

0.40

g/l

—

Abnormalities of breathing

269

753

2.08

24.94

1.2

0.52

0.55

g/l

0.03

Osteopathies and chondropathies

186

751

2.31

24.89

1.3

1.2

1.16

0.30

g/l

—

Gout

262

3.27

24.83

1.2

0.82

0.48

g/l

—

All-cause Heart Failure

176

512

2.43

24.76

1.3

1.2

0.28

0.83

g/l

1.00

Provisional assignment of new diseases of uncertain etiology

177

758

2.34

24.61

1.2

0.64

0.37

g/l

0.26

Codes for special purposes

177

759

2.34

24.54

1.2

0.64

0.37

g/l

0.26

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

205

834

2.21

24.30

1.3

1.2

0.55

0.54

g/l

0.01

Dental caries

100

314

3.08

23.66

1.3

1.1

0.16

0.27

g/l

—

Asthma

227

544

2.19

23.36

1.2

1.58

0.39

g/l

—

Cerebrovascular diseases

228

758

2.12

23.27

1.1

1.2

0.15

0.64

g/l

1.99

Metabolic disorders

282

871

1.98

23.24

1.2

0.37

0.43

g/l

0.10

Arthropathies

272

677

2.04

23.16

1.2

0.19

0.53

g/l

0.94

Other heart diseases, wide

274

843

1.99

22.99

1.2

0.21

0.68

g/l

1.29

Symptoms and signs involving the circulatory and respiratory systems

297

757

1.97

22.94

1.2

0.26

0.55

g/l

0.81

Diseases of the eye and adnexa

241

568

2.13

22.83

1.3

1.1

0.26

0.16

g/l

0.42

Complications of procedures, not elsewhere classified

246

1012

2.02

22.80

1.3

1.2

0.44

0.52

g/l

0.15

Parasetamol

217

497

2.22

22.71

1.3

1.2

0.24

0.55

g/l

0.55

Asthma (mode)

222

548

2.17

22.55

1.2

1.05

0.39

g/l

—

Asthma (only as main-diagnosis), excluding more controls

196

497

2.26

22.22

1.1

1.2

1.05

0.40

g/l

—

Pain in throat and chest

248

731

2.04

22.18

1.1

1.2

0.36

0.56

g/l

—

Bleeding

243

855

2.03

22.14

1.2

1.04

0.43

g/l

0.59

Gout, FINNGEN

326

2.98

21.96

1.2

0.82

0.45

g/l

—

Implicit viral Sepsis

233

3.37

21.62

1.3

1.1

0.07

0.53

g/l

—

Viral Sepsis

233

3.37

21.62

1.3

1.1

0.07

0.53

g/l

—

Rash and other nonspecific skin eruption

110

4.59

21.22

1.2

—

0.26

g/l

—

Rheumatoid arthritis

110

360

2.75

21.03

1.1

1.2

0.25

0.40

g/l

—

Heart failure and bmi 25plus

110

261

2.86

20.93

1.3

1.2

0.14

1.00

g/l

—

Persons encountering health services for specific procedures and health care

312

1016

1.84

20.87

1.3

1.2

0.46

0.57

g/l

0.17

Haemorrhage from respiratory passages

110

364

2.73

20.83

1.2

0.42

0.81

g/l

—

Asthma (only as main-diagnosis)

202

544

2.15

20.55

1.2

0.93

0.39

g/l

—

Pain (limb, back, neck, head abdominally)

202

465

2.18

20.34

1.2

0.24

0.21

g/l

0.11

Hard cardiovascular diseases

247

749

1.97

20.08

1.2

0.16

0.73

g/l

1.90

Dorsalgia

286

815

1.88

19.86

1.2

0.56

0.58

g/l

0.01

Amputation

100

4.64

19.80

1.4

1.2

1.23

0.30

g/l

—

COPD differential diagnosis

225

548

2.06

19.72

1.2

0.20

0.39

g/l

0.49

ILD differential diagnosis

225

548

2.06

19.72

1.2

0.20

0.39

g/l

0.49

Caries of dentine

285

2.98

19.67

1.3

1.1

0.16

0.27

g/l

—

Excluding asthma or asthma-COPD overlap

225

550

2.05

19.54

1.2

0.20

0.39

g/l

0.49

Any reimbursement code in KELA

165

355

2.33

19.42

1.2

0.11

0.22

g/l

—

Diseases of liver

118

471

2.52

19.37

1.1

1.2

0.31

0.18

g/l

—

Other pulmonary diagnosis

223

550

2.04

18.94

1.2

0.20

0.39

g/l

0.49

Endocrine, nutritional and metabolic diseases

227

571

2.02

18.89

1.2

0.25

0.58

g/l

0.73

Low back pain

219

802

1.96

18.48

1.3

1.2

0.57

0.59

g/l

—

Neurological diseases

235

599

1.97

18.44

1.2

0.30

0.49

g/l

0.43

COPD/asthma related infections

286

778

1.84

18.37

1.2

0.28

0.65

g/l

0.83

COPD/asthma/ILD related infections

286

778

1.84

18.37

1.2

0.28

0.65

g/l

0.83

Non-ischemic cardiomyopathy

100

297

2.72

18.32

1.4

1.2

0.36

0.64

g/l

0.34

Peripheral artery operations in Hilmo

115

4.20

18.30

1.4

1.1

1.04

0.28

g/l

—

Asthma, unspecified (mode)

150

505

2.24

18.02

1.3

1.2

1.21

0.43

g/l

—

Stroke, excluding SAH

179

626

2.09

18.00

1.1

1.2

0.17

0.66

g/l

—

Intestinal infectious diseases

322

1054

1.75

17.97

1.2

0.60

0.52

g/l

0.08

Disorders of other endocrine glands

139

607

2.26

17.95

1.2

0.33

0.27

g/l

—

Asthma, unspecified (mode), excluding more controls

141

460

2.30

17.92

1.3

1.2

1.21

0.43

g/l

—

DVT of lower extremities and pulmonary embolism

129

554

2.33

17.88

1.3

1.2

0.63

0.22

g/l

—

Rheumatoid arthritis, including avohilmo

126

543

2.33

17.53

1.1

1.2

0.22

0.28

g/l

—

Other disorders of fluid, electrolyte and acid-base balance

362

2.61

17.47

1.3

1.2

0.16

0.18

g/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

207

968

1.93

17.37

1.2

0.89

0.47

g/l

—

Nerve, nerve root and plexus disorders

298

1039

1.76

17.31

1.2

0.53

0.54

g/l

0.01

Viral infections characterized by skin and mucous membrane lesions

245

1147

1.83

17.28

1.3

1.2

0.58

0.51

g/l

0.10

Stroke, including SAH

185

662

2.03

17.22

1.1

1.3

0.17

0.70

g/l

—

Intestinal infectious diseases

267

1133

1.79

17.20

1.2

0.74

0.50

g/l

0.20

Genitourinary diseases

166

379

2.20

17.19

1.2

0.15

0.67

g/l

0.94

Atrial fibrillation and flutter

201

2.88

17.08

1.2

1.1

0.12

0.30

g/l

0.91

Complications of medical and surgical care

213

1036

1.89

16.97

1.3

1.2

0.61

0.55

g/l

0.07

Abnormal findings on diagnostic imaging of lung

142

624

2.19

16.91

1.4

1.2

0.33

0.55

g/l

—

Other respiratory diseases principally affecting the interstitium

204

3.20

16.74

1.3

1.2

0.26

0.23

g/l

—

Episodal and paroxysmal disorders

307

895

1.75

16.73

1.2

0.34

0.45

g/l

0.29

Other bacterial intestinal infections

231

3.05

16.58

1.3

1.1

0.08

0.24

g/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

168

2.84

16.41

1.1

0.06

0.11

g/l

—

Peripheral arterial reconstruction

187

3.28

16.33

1.2

0.72

0.24

g/l

—

Other bacterial intestinal infections

311

2.71

16.14

1.2

1.1

0.08

0.26

g/l

—

Other disorders of urethra and urinary system

197

735

1.94

16.10

1.2

0.46

0.52

g/l

0.07

Fall on same level

313

1001

1.71

16.08

1.2

0.29

0.57

g/l

0.61

Concussion

133

490

2.22

15.95

1.2

0.15

0.54

g/l

—

Intracranial trauma

151

500

2.13

15.79

1.3

1.2

0.09

0.54

g/l

—

Cardiac arrhythmias

165

520

2.07

15.72

1.2

0.23

0.80

g/l

1.29

Ischaemic Stroke, excluding all haemorrhages

163

593

2.05

15.69

1.1

1.2

0.19

0.67

g/l

—

Other joint disorders

237

677

1.85

15.67

1.2

0.12

0.53

g/l

—

Hypothyroidism, strict autoimmune

169

548

2.03

15.46

1.2

0.36

0.53

g/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

177

439

2.05

15.40

1.2

1.1

0.20

0.23

g/l

0.10

Mycoses

366

2.52

15.32

1.4

1.2

1.25

0.21

g/l

—

Other dorsopathies, not elsewhere classified

273

816

1.75

15.19

1.2

0.44

0.58

g/l

0.19

Pyoderma gangrenosum

16.26

15.18

1.4

1.0

—

g/l

—

Bacterial intestinal infections, IBD co-morbidities

234

2.92

15.00

1.3

1.2

0.08

0.24

g/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

276

1063

1.71

14.96

1.2

0.68

0.52

g/l

0.16

Disorders of lens

182

582

1.96

14.83

1.3

1.2

0.32

0.67

g/l

0.64

Spondylopathies

215

695

1.85

14.75

1.2

0.73

0.54

g/l

—

Gout, idiopatic and unspecified

303

2.65

14.74

1.2

0.71

0.51

g/l

—

Symptoms and signs involving the digestive system and abdomen

267

766

1.75

14.60

1.2

0.13

0.41

g/l

1.28

Other and unspecified iron deficiency

104

448

2.33

14.55

1.3

1.2

0.96

0.22

g/l

—

Methotrexate

127

3.64

14.50

1.0

1.1

1.09

0.27

g/l

—

Lower back pain or/and sciatica

287

1117

1.68

14.47

1.3

1.2

0.53

0.54

g/l

0.01

Seropositive rheumatoid arthritis

282

2.69

14.46

1.1

1.2

0.24

0.31

g/l

—

Asthma-related infections

168

855

1.93

14.37

1.2

0.19

0.31

g/l

—

Asthma, hospital admission 2, infections

168

855

1.93

14.37

1.2

0.19

0.31

g/l

—

Other diseases of urinary system

268

875

1.72

14.35

1.1

1.2

0.25

0.57

g/l

0.94

Gout, unspecified

251

2.80

14.35

1.2

0.80

0.27

g/l

—

Medical observation and evaluation for suspected diseases and conditions

172

439

2.01

14.33

1.2

1.1

0.87

0.23

g/l

—

Disorders of eyelid, lacrimal system and orbit

233

1006

1.76

14.32

1.2

0.53

0.58

g/l

0.06

Acute tubulo-interstitial nephritis

162

716

1.96

14.15

1.3

1.2

0.82

0.63

g/l

0.16

Injuries to the head

300

1116

1.65

14.11

1.2

0.14

0.62

g/l

2.38

Visual disturbances and blindness

151

764

1.98

14.03

1.4

1.2

0.80

0.34

g/l

—

Cellulitis

294

2.63

13.99

1.3

1.2

0.17

0.25

g/l

—

Atopic dermatitis

155

643

1.98

13.88

1.2

0.48

0.29

g/l

—

Viral infections characterized by skin and mucous membrane lesions

125

593

2.11

13.83

1.4

1.2

0.35

0.21

g/l

0.28

Fibromyalgia

4.30

13.81

1.1

—

0.10

g/l

—

Varicose veins

162

627

1.95

13.79

1.1

1.2

0.74

0.55

g/l

—

Gastrointestinal diseases

166

415

2.01

13.78

1.2

0.26

0.58

g/l

0.57

Disorders of sclera, cornea, iris and ciliary body

160

832

1.93

13.76

1.3

1.2

0.54

0.22

g/l

1.03

Spondylosis

147

599

2.00

13.64

1.3

1.2

1.05

0.58

g/l

—

Abdominal and pelvic pain

262

766

1.72

13.60

1.2

0.56

0.41

g/l

0.17

Asthma, including avohilmo

315

1093

1.62

13.43

1.2

1.33

0.42

g/l

—

Neoplasms

207

600

1.83

13.38

1.2

0.27

0.17

g/l

0.38

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

172

912

1.87

13.37

1.3

1.2

0.77

0.59

g/l

0.16

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

258

996

1.69

13.30

1.2

0.29

0.63

g/l

0.97

Syncope and collapse

105

400

2.25

13.26

1.1

1.2

0.64

0.59

g/l

—

Dorsopathies

271

818

1.69

13.14

1.2

0.23

0.58

g/l

1.02

Cystitis

228

775

1.75

13.13

1.1

1.2

0.90

0.62

g/l

0.25

Mycoses

230

1171

1.71

13.11

1.3

1.2

1.03

0.41

g/l

0.70

Psoriasis

396

2.33

12.98

1.1

1.2

0.05

0.22

g/l

—

Polyarteritis nodosa

33.94

12.72

1.3

1.0

—

g/l

—

Visual disturbances

138

703

1.97

12.65

1.4

1.2

0.80

0.25

g/l

—

Non-follicular lymphoma

116

3.56

12.52

1.9

1.2

1.46

0.10

g/l

—

Zoster [herpes zoster]

136

681

1.97

12.48

1.4

1.2

0.85

0.57

g/l

0.27

Symptoms and signs involving the nervous and musculoskeletal systems

160

860

1.86

12.46

1.2

0.32

0.51

g/l

—

Cardiomyopathy

182

2.98

12.43

1.1

0.21

0.91

g/l

—

297

949

1.62

12.43

1.2

0.28

0.58

g/l

0.86

Non-rheumatic valve diseases

121

417

2.10

12.41

1.2

0.57

1.05

g/l

0.38

Valvular heart disease excluding rheumatic fever

121

418

2.09

12.36

1.2

0.57

1.05

g/l

0.38

Lymphoid leukaemia

4.71

12.36

1.8

1.2

0.31

0.06

g/l

—

Subjective visual disturbances

338

2.41

12.28

1.5

1.2

0.34

0.31

g/l

—

Other antidepressants

270

837

1.65

12.28

1.2

0.68

0.41

g/l

0.27

Iron deficiency anaemia

119

573

2.05

12.23

1.3

1.2

0.96

0.22

g/l

—

Diseases of oesophagus, stomach and duodenum

276

1017

1.62

12.12

1.2

1.08

0.38

g/l

0.69

Myalgia

275

2.55

12.07

1.1

1.2

—

0.24

g/l

—

Falls/tendency to fall

283

871

1.63

12.06

1.2

0.14

0.50

g/l

1.69

Senile cataract

157

506

1.90

11.92

1.4

1.2

0.37

0.75

g/l

0.60

Asthma (diagnoses ohter than nonallergic)

231

1152

1.67

11.89

1.2

1.21

0.48

g/l

—

Gout, strict definition

220

2.74

11.87

1.2

0.12

0.26

g/l

—

Nausea and vomiting

312

2.42

11.86

1.4

1.2

0.57

0.28

g/l

—

Heart failure and coronary heart disease

117

400

2.08

11.67

1.2

0.11

0.76

g/l

1.56

Diseases of the respiratory system

171

460

1.87

11.62

1.2

0.23

0.43

g/l

0.41

Persons encountering health services for examination and investigation

165

439

1.89

11.62

1.2

1.1

0.23

g/l

0.00

Sulfasalazine

293

2.46

11.54

1.2

1.1

0.18

0.24

g/l

—

Nutritional anaemias

133

665

1.93

11.53

1.3

1.2

1.13

0.21

g/l

—

Diabetic nephropathy, excluding more controls

118

3.22

11.51

1.2

0.11

1.12

g/l

—

Sequelae of cerebrovascular disease

101

406

2.15

11.50

1.1

1.2

0.21

0.51

g/l

—

Bacterial pneumonia, not elsewhere classified

104

433

2.12

11.46

1.3

1.1

0.14

0.62

g/l

—

Mood disorders, excluding more controls

252

923

1.63

11.30

1.3

1.2

0.80

0.52

g/l

—

Bacterial pneumoniae

107

456

2.07

11.14

1.3

1.1

0.14

0.59

g/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

157

877

1.79

10.84

1.3

1.2

0.77

0.51

g/l

0.25

Chronic apical periodontitis

292

1067

1.56

10.80

1.3

1.2

1.05

0.31

g/l

1.38

Bronchitis

276

1107

1.57

10.76

1.2

0.40

0.57

g/l

0.27

Other diseases of pleura

118

525

1.97

10.76

1.3

1.2

0.17

0.64

g/l

—

Other acute lower respiratory infections

142

735

1.84

10.71

1.2

0.19

0.25

g/l

—

Other and unspecified effects of external causes

387

2.20

10.59

1.2

0.16

0.22

g/l

—

Type 2 diabetes, wide definition

203

771

1.69

10.53

1.2

0.12

0.62

g/l

1.99

Other diseases of intestines

268

965

1.58

10.51

1.2

0.28

0.48

g/l

0.52

Bacterial pneumonia (organism specified)

117

543

1.96

10.49

1.3

1.2

0.13

0.53

g/l

1.11

Disorders of lipoprotein metabolism and other lipidaemias

201

737

1.69

10.44

1.2

0.19

0.45

g/l

0.78

Symptoms and signs involving speech and voice

476

2.07

10.36

1.2

0.73

0.17

g/l

—

Constipation

227

969

1.62

10.32

1.2

0.59

0.52

g/l

0.06

Sequelae of external causes of morbidity and mortality

360

2.23

10.27

1.2

0.06

0.34

g/l

—

Acute bronchitis

110

547

1.98

10.27

1.2

0.16

0.30

g/l

—

Anxiety disorders, excluding more controls

218

873

1.63

9.90

1.3

1.2

0.51

0.54

g/l

—

Accidents

199

590

1.69

9.89

1.2

0.27

0.45

g/l

0.45

Other external causes of accidental injury

199

590

1.69

9.89

1.2

0.26

0.45

g/l

0.50

Hypertensive heart and/or renal disease

206

2.43

9.89

1.1

1.2

0.19

0.49

g/l

—

Factors influencing health status and contact with health services

149

2.46

9.89

1.3

1.1

0.08

0.15

g/l

—

Benign neoplasms

252

883

1.57

9.70

1.2

0.19

0.47

g/l

1.08

Use of hypnotics and sedatives

273

1017

1.54

9.69

1.3

1.1

0.65

0.45

g/l

0.25

Anxiety (asthma-related co-morbidities)

167

752

1.72

9.68

1.3

1.2

0.53

0.37

g/l

—

Chronic lower respiratory diseases

303

1069

1.51

9.63

1.2

1.19

0.43

g/l

0.58

Acute upper respiratory infections

261

1040

1.55

9.54

1.2

0.30

0.55

g/l

0.67

All influenza

314

2.27

9.52

1.3

1.1

0.18

0.32

g/l

—

Disorders of choroid and retina

200

871

1.63

9.43

1.2

0.68

0.53

g/l

—

Zoster [herpes zoster]

224

2.51

9.40

1.4

1.2

0.58

0.27

g/l

—

Papulosquamous disorders

111

584

1.91

9.40

1.1

1.2

0.05

0.31

g/l

—

Depression or dysthymia

173

557

1.72

9.31

1.2

0.61

0.49

g/l

0.09

All anxiety disorders

169

790

1.69

9.30

1.3

1.2

0.53

0.28

g/l

—

Mood [affective] disorders

260

1099

1.53

9.27

1.2

0.80

0.51

g/l

—

Mood disorders

260

1100

1.53

9.17

1.2

0.80

0.51

g/l

—

Statin medication

188

636

1.66

9.09

1.1

1.2

0.13

0.48

g/l

—

Symptoms and signs involving the urinary system

190

888

1.63

9.06

1.4

1.2

1.11

0.37

g/l

0.96

Chronic lymphocytic leukaemia, helper endpoint

7.53

8.95

2.0

1.4

0.35

0.08

g/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

7.53

8.95

1.9

1.4

0.35

0.08

g/l

—

Chronic lymphocytic leukaemia

7.53

8.95

2.0

1.4

0.35

0.08

g/l

—

Pure hypercholesterolaemia

174

679

1.67

8.90

1.2

0.19

0.46

g/l

0.84

Other disorders of kidney and ureter

166

2.73

8.90

1.4

1.2

0.04

0.31

g/l

—

Care involving use of rehabilitation procedures

159

868

1.69

8.88

1.3

1.2

0.17

0.62

g/l

—

External causes of morbidity and mortality

160

461

1.74

8.86

1.2

0.27

0.33

g/l

0.16

Asthma, hospital admissions , main diagnosis only

207

1157

1.58

8.86

1.2

0.93

0.50

g/l

—

Voice disturbances

364

2.12

8.81

1.2

1.1

0.78

0.13

g/l

—

Neurotic, stress-related and somatoform disorders

229

1035

1.55

8.68

1.3

1.2

0.44

0.58

g/l

—

Depression

241

1066

1.53

8.67

1.2

0.81

0.52

g/l

—

Anxiety disorders

230

1041

1.54

8.52

1.3

1.2

0.46

0.58

g/l

0.17

Atrial fibrillation and flutter with reimbursement

154

2.44

8.48

1.2

0.16

0.31

g/l

—

Benzodiazepine use

250

1142

1.51

8.38

1.3

1.2

0.93

0.49

g/l

—

Seropositive rheumatoid arthritis, wide

366

2.08

8.32

1.1

1.2

0.24

0.31

g/l

—

Disorders of skin appendages

129

741

1.74

8.24

1.1

1.2

0.42

0.26

g/l

—

Disorders of gallbladder, biliary tract and pancreas

242

1008

1.52

8.17

1.3

1.2

0.31

0.61

g/l

0.80

Triptan medication for migraine, min. 3 purchases

149

674

1.69

8.16

1.2

0.99

0.21

g/l

—

Acute upper respiratory infections of multiple and unspecified sites

188

879

1.59

8.02

1.2

0.44

0.35

g/l

0.12

Injury, poisoning and certain other consequences of external causes

138

393

1.76

8.02

1.2

0.27

0.51

g/l

0.48

Selective serotonin reuptake inhibitors

243

837

1.52

7.95

1.2

0.47

0.41

g/l

0.09

Hypertensive Heart Disease

192

2.33

7.84

1.1

1.2

0.21

0.49

g/l

—

General examination and investigation of persons without complaint and reported diagnosis

144

438

1.72

7.76

1.3

1.1

0.25

0.23

g/l

—

Other diseases of lip and oral mucosa

106

587

1.81

7.73

1.3

1.2

0.13

0.28

g/l

—

Symptoms and signs concerning food and fluid intake

3.19

7.63

1.2

1.1

—

0.07

g/l

—

Persons with potential health hazards related to communicable diseases

104

571

1.81

7.57

1.1

1.2

1.14

0.23

g/l

—

Periodontitis

235

1053

1.49

7.54

1.3

1.2

0.65

0.54

g/l

0.13

Superficial injury of head

307

2.12

7.52

1.1

1.2

0.17

0.34

g/l

—

Rosacea

158

2.61

7.51

1.1

1.2

—

0.15

g/l

—

Intracranial injury

140

801

1.66

7.41

1.2

0.14

0.49

g/l

—

Operations 2 for CAVS

340

2.03

7.27

1.3

1.2

0.75

0.34

g/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

340

2.03

7.27

1.3

1.2

0.75

0.34

g/l

—

Chronic periodontitis, including avohilmo

233

1054

1.48

7.24

1.3

1.2

0.65

0.54

g/l

0.13

Calcific aortic valvular stenosis

341

2.02

7.22

1.3

1.2

0.75

0.34

g/l

—

Calcific aortic valvular stenosis, operated

341

2.02

7.22

1.3

1.2

0.75

0.34

g/l

—

Other functional intestinal disorders

109

576

1.76

7.18

1.2

0.17

0.39

g/l

—

Disorders of the thyroid gland

229

1005

1.49

7.14

1.1

1.2

0.47

0.53

g/l

0.08

Other anxiety disorders

124

634

1.70

7.13

1.4

1.1

0.66

0.28

g/l

—

Persons encountering health services in other circumstances

513

1.83

7.10

1.1

1.2

0.31

0.17

g/l

—

Diabetic nephropathy

190

2.40

7.09

1.2

0.11

0.59

g/l

—

Adverse effects, not elsewhere classified

275

2.15

7.09

1.3

1.2

0.14

0.24

g/l

—

Calcific aortic valvular stenosis, including rheumatic fever

343

2.01

7.09

1.3

1.2

0.75

0.34

g/l

—

Other/unspecified seropositive rheumatoid arthritis

364

1.98

6.98

1.1

1.2

0.24

0.31

g/l

—

Substance abuse, excluding more controls

134

692

1.65

6.97

1.4

1.2

0.21

0.35

g/l

—

Ischemic heart diseases

196

770

1.53

6.94

1.3

1.2

0.16

0.69

g/l

1.90

Other retinal disorders

149

721

1.61

6.92

1.2

0.93

0.60

g/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

359

1.98

6.88

1.1

1.2

0.24

0.31

g/l

—

Irregular menses

121

564

1.70

6.86

1.2

1.49

0.46

g/l

—

Injuries to the knee and lower leg

285

1115

1.42

6.84

1.2

0.67

0.51

g/l

—

Sciatica+with lumbago

124

683

1.67

6.84

1.3

1.2

0.32

0.60

g/l

—

Other cataract

105

450

1.77

6.83

1.3

1.2

0.09

0.61

g/l

—

Any death

147

654

1.61

6.73

1.2

0.25

0.78

g/l

1.44

Keratitis

515

1.79

6.55

1.2

0.38

0.25

g/l

—

Other neurological diseases

170

871

1.54

6.46

1.1

1.2

0.24

0.59

g/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

144

832

1.58

6.41

1.2

0.08

0.53

g/l

2.00

Unspecified haematuria

469

1.75

6.38

1.5

1.2

1.11

0.15

g/l

—

Dermatophytosis

147

937

1.57

6.38

1.3

1.2

1.53

0.23

g/l

—

Haemophagocytic lymphohistiocytosis

+∞

6.37

1.3

0.0

—

g/l

—

Insulin medication

144

771

1.57

6.17

1.2

0.08

0.42

g/l

1.88

Other intervertebral disc disorders

189

761

1.50

6.11

1.1

1.2

0.41

0.59

g/l

—

Candidiasis

397

1.87

6.07

1.2

0.68

0.19

g/l

—

Pleural effusion

182

2.32

6.06

1.3

1.2

0.19

0.25

g/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

228

1086

1.43

6.04

1.2

0.50

0.55

g/l

0.06

Insulin, fast-acting

506

1.76

6.04

1.2

0.09

0.47

g/l

—

Dysphagia

302

1.99

5.95

1.1

1.2

0.18

0.30

g/l

—

Disorders of synovium and tendon

118

634

1.63

5.94

1.1

1.2

0.56

0.50

g/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

219

999

1.44

5.92

1.2

0.52

g/l

—

Insulin, intermediate and long-acting

128

783

1.59

5.90

1.1

1.2

0.08

0.53

g/l

1.86

Any mental disorder

263

939

1.40

5.88

1.2

0.81

0.51

g/l

0.26

Other nutritional deficiencies

159

992

1.51

5.81

1.2

0.14

0.58

g/l

—

Malignant neoplasm, wide definition for exclusion

207

836

1.45

5.78

1.2

1.1

0.49

0.26

g/l

0.46

Hypothyroidism, other/unspecified

210

959

1.44

5.74

1.2

0.57

0.55

g/l

—

Insulin, fast-acting or short human

515

1.73

5.70

1.2

0.09

0.47

g/l

—

5-aminosalicylic acid

201

2.19

5.63

1.2

1.1

—

0.28

g/l

—

Substance abuse

134

812

1.55

5.57

1.4

1.2

0.21

0.43

g/l

—

Benign neoplasm of colon, rectum, anus and anal canal

141

797

1.54

5.55

1.2

0.20

0.63

g/l

—

Myelodysplastic syndrome, including Hilmo

5.89

5.54

1.2

1.4

—

0.06

g/l

—

Weight loss

122

2.55

5.53

1.2

1.3

—

0.23

g/l

—

Ganglion

243

2.06

5.48

1.1

—

0.13

g/l

—

Coxarthrosis [arthrosis of hip](FG)

105

446

1.66

5.46

1.2

0.20

0.42

g/l

—

Asthma and allergy, excluding more controls

139

2.42

5.44

1.1

1.2

—

0.18

—

Mental and behavioural disorders due to psychoactive substance use

137

829

1.53

5.38

1.3

1.2

0.21

0.44

g/l

—

Other and unspecified rosacea

118

2.56

5.37

1.1

1.2

—

0.16

g/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

2.75

5.36

1.4

1.2

1.18

0.06

g/l

—

Asthma and allergy

140

2.40

5.36

1.1

1.2

—

0.18

—

Diseases of the digestive system

104

636

1.63

5.35

1.2

1.55

0.32

g/l

—

Visual field defects

101

2.69

5.33

1.1

1.3

—

0.24

g/l

—

Open wound of ankle and foot

137

2.42

5.28

1.4

1.1

0.58

0.10

g/l

—

Diseases of pulp and periapical tissues, including avohilmo

245

914

1.39

5.26

1.3

1.2

0.34

0.29

g/l

0.11

Ischaemic heart disease, wide definition

172

724

1.47

5.24

1.2

0.10

0.62

g/l

2.28

Olecranon bursitis

3.14

5.19

1.2

—

0.16

g/l

—

Diverticular disease of intestine

155

662

1.50

5.14

1.2

1.25

0.51

g/l

—

Triptan medication for migraine, single purchase ok

183

859

1.44

5.14

1.3

1.2

0.33

0.28

g/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

183

859

1.44

5.14

1.3

1.2

0.33

0.28

g/l

—

Gingivitis and periodontal diseases

233

864

1.39

5.08

1.2

0.28

0.49

g/l

0.47

Sleep disorders (combined)

261

1004

1.37

5.07

1.1

1.2

0.31

0.52

g/l

0.60

Diabetes mellitus

237

1003

1.38

5.07

1.2

0.16

0.59

g/l

1.95

GI-bleeding

419

1.75

4.88

1.3

1.2

1.78

0.33

g/l

—

Nonischemic cardiomyopathy

118

2.47

4.85

1.2

1.1

0.64

0.44

g/l

—

Gastro-oesophageal reflux disease

149

873

1.47

4.85

1.2

0.98

0.34

g/l

0.53

Unspecified fall

115

732

1.55

4.84

1.2

0.11

0.38

g/l

—

Psychiatric diseases

230

836

1.38

4.74

1.2

0.18

0.55

g/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

374

1.65

4.73

1.2

1.1

0.24

0.23

g/l

—

Diseases of pulp and periapical tissues and dental caries

155

537

1.48

4.71

1.2

1.1

0.12

0.23

g/l

0.87

491

1.65

4.70

1.3

1.2

1.26

0.39

g/l

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

500

1.66

4.68

1.1

1.2

0.72

0.22

g/l

—

Lumbar disc prolapse

141

730

1.48

4.67

1.2

0.43

0.59

g/l

—

Shoulder lesions

157

651

1.46

4.65

1.2

0.99

0.48

g/l

—

Presence of other functional implants

126

575

1.52

4.64

1.3

1.2

0.38

0.79

g/l

0.67

Obesity and other hyperalimentation

147

974

1.46

4.59

1.2

0.14

0.59

g/l

—

Other diseases of hard tissues of teeth

134

458

1.52

4.57

1.1

0.39

0.27

g/l

—

Malignant neoplasm

189

797

1.40

4.50

1.2

1.1

0.53

0.26

g/l

0.49

Type 1 diabetes

348

1.78

4.49

1.2

0.08

0.25

g/l

—

Missing teeth due to accident, extraction or parodontitis

132

841

1.48

4.48

1.3

1.2

0.32

0.62

g/l

—

Major coronary heart disease event

183

784

1.41

4.48

1.3

1.2

0.17

0.67

g/l

1.82

Diabetes, varying definitions

232

1005

1.35

4.44

1.2

0.16

0.59

g/l

1.95

Disorders of conjunctiva

190

1102

1.38

4.41

1.1

1.2

0.67

0.53

g/l

—

Exposure to other and unspecified forces of nature

7.76

4.40

1.3

1.0

—

Cholelithiasis

185

916

1.39

4.35

1.2

0.31

0.65

g/l

0.89

Percutaneous Coronary Intervention

170

735

1.42

4.34

1.3

1.2

0.17

0.69

g/l

1.86

Obesity

145

972

1.44

4.32

1.2

0.14

0.59

g/l

—

Arthrosis

151

572

1.45

4.24

1.2

0.20

0.55

g/l

—

Cholelithiasis, broad definition with cholecystitis

191

933

1.38

4.21

1.3

1.2

0.36

0.64

g/l

0.68

Actinic keratosis

447

1.64

4.21

1.3

1.2

1.26

0.40

g/l

—

Conjunctivitis

174

1045

1.39

4.20

1.1

1.2

0.74

0.40

g/l

—

Visual impairment including blindness (binocular or monocular)

2.75

4.18

1.2

—

0.32

g/l

—

Migraine without aura and triptan purchases

215

1.96

4.09

1.1

1.2

—

0.22

g/l

—

Occupational exposure to risk-factors

3.10

4.09

1.1

1.3

—

0.07

g/l

—

Bullous disorders

2.72

4.08

1.2

1.3

—

0.11

g/l

—

Systemic disorders of connective tissue in diseases classified elsewhere

10.43

4.05

1.3

1.1

—

Rotator cuff syndrome

122

591

1.48

4.05

1.3

1.2

1.08

0.43

g/l

—

Crohn's disease NAS

2.57

4.05

1.2

—

0.04

—

COPD

480

1.57

4.05

1.3

1.2

1.02

0.34

g/l

—

Type 2 diabetes

221

963

1.34

4.03

1.2

0.17

0.62

g/l

1.97

Skin changes due to chronic exposure to nonionizing radiation

459

1.61

3.99

1.3

1.2

1.26

0.40

g/l

—

Other diseases of upper respiratory tract

246

972

1.32

3.94

1.2

0.70

0.48

g/l

0.22

Cardiodefibrillation

462

1.62

3.91

1.2

0.12

0.71

g/l

—

Open wound of head

111

721

1.49

3.91

1.1

1.2

0.18

0.48

g/l

—

Sleep apnoea

210

1015

1.34

3.89

1.1

1.2

0.71

0.52

g/l

0.19

Secondary uncertain malignant neoplasm

138

2.18

3.88

1.3

1.2

1.18

0.09

g/l

—

Coronary revascularization (ANGIO or CABG)

167

735

1.39

3.88

1.3

1.2

0.17

0.69

g/l

1.86

Orchitis and epididymitis

114

2.29

3.77

1.2

—

0.12

g/l

—

Coxarthrosis

423

1.53

3.77

1.2

0.20

0.54

g/l

—

Chronic periodontitis, complicated

119

813

1.45

3.77

1.3

1.2

0.44

0.53

g/l

0.12

Abnormal weight loss

115

2.27

3.70

1.2

1.3

—

0.25

g/l

—

Trigeminal neuralgia

2.70

3.65

1.1

1.2

—

0.36

g/l

—

Other diseases of the digestive system

418

1.63

3.64

1.3

1.2

1.78

0.33

g/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

184

921

1.35

3.63

1.2

0.29

0.54

g/l

—

Caries of dentine, including avohilmo

179

670

1.37

3.61

1.2

0.32

0.45

g/l

0.23

Diseases of oral cavity, salivary glands and jaws

129

459

1.45

3.61

1.2

1.1

0.12

0.27

g/l

1.00

Aortic aneurysm

228

1.85

3.59

1.2

0.13

0.56

g/l

—

Polycystic ovarian syndrome, consortium definition

158

676

1.39

3.59

1.2

0.37

0.42

g/l

—

Other pleural conditions

117

2.23

3.57

1.7

1.2

0.24

0.33

g/l

—

Excessive vomiting in pregnancy

111

2.26

3.54

1.1

—

0.19

g/l

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

6.30

3.52

1.1

—

Open wound of forearm

118

2.21

3.50

1.0

1.2

—

0.24

—

AV-block

149

2.00

3.50

1.1

1.2

—

1.09

g/l

—

Disorders of continuity of bone

125

2.17

3.47

1.2

—

0.29

g/l

—

Melanocytic naevi

424

1.61

3.46

1.1

1.2

0.12

0.21

g/l

—

Dental caries, including avohilmo

166

620

1.37

3.44

1.2

0.33

0.47

g/l

0.23

Retinal vascular occlusion

127

2.13

3.35

1.1

1.3

—

0.45

g/l

—

Other Crohn's disease

2.33

3.33

1.2

1.1

—

0.04

g/l

—

Alcohol use disorder, Swedish definition

117

755

1.42

3.33

1.2

0.18

0.47

g/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

116

651

1.43

3.32

1.1

1.3

0.09

0.62

g/l

—

128

807

1.40

3.29

1.2

0.18

0.44

g/l

—

Other chronic obstructive pulmonary disease

463

1.51

3.28

1.3

1.2

1.20

0.33

g/l

—

122

785

1.41

3.26

1.2

0.19

0.46

g/l

—

Diaphragmatic hernia

503

1.53

3.23

1.4

1.2

1.34

0.38

g/l

—

Any event in cancer register

200

899

1.31

3.21

1.2

0.57

0.27

g/l

0.54

Injuries to the ankle and foot

156

1031

1.35

3.19

1.3

1.2

0.98

0.39

g/l

—

Retinal vascular disorders

130

2.08

3.17

1.1

1.2

—

0.45

g/l

—

Postmenopausal osteoporosis with pathological fracture

2.55

3.12

1.2

—

0.91

g/l

—

Other viral diseases, not elsewhere classified

253

1.74

3.04

1.1

1.2

—

0.21

g/l

—

Obesity due to excess calories

105

741

1.42

3.02

1.2

0.14

0.25

g/l

—

Hypersplenism

10.26

3.00

1.2

1.0

—

Asthma and opportunity respiratory infection

2.65

2.96

1.2

—

0.43

—

Benign neoplasm: Colon

110

750

1.40

2.95

1.2

0.22

0.64

g/l

—

Other medical care

564

1.45

2.94

1.2

0.88

0.76

g/l

—

Crohn disease (strict definition, require KELA)

2.28

2.93

1.3

1.1

—

0.04

g/l

—

Other symptoms and signs involving cognitive functions and awareness

587

1.44

2.92

1.1

1.2

0.53

0.30

g/l

—

Cholecystectomy

150

971

1.33

2.91

1.2

0.40

0.62

g/l

—

Fall on same level involving ice and snow

123

904

1.36

2.81

1.3

1.2

0.56

0.59

g/l

—

Osteonecrosis due to drugs

4.50

2.80

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

105

619

1.40

2.80

1.3

1.2

0.72

0.46

g/l

—

Sub-endpoint used in defining T1D endpoints

402

1.54

2.78

1.2

0.08

0.23

g/l

—

Other or unspecified immunodeficiency

8.59

2.77

1.0

—

g/l

—

Myocardial infarction

473

1.43

2.76

1.1

1.2

0.05

0.72

g/l

—

Dizziness and giddiness

157

947

1.31

2.76

1.3

1.2

0.40

0.55

g/l

—

Emergency coronary revascularization (for ACS)

174

812

1.30

2.76

1.3

1.2

0.17

0.67

g/l

1.82

Sleep apnoea, including avohilmo

216

1058

1.26

2.73

1.1

1.2

0.71

0.51

g/l

0.19

Dental pulpitis, including avohilmo

199

1013

1.28

2.71

1.3

1.2

0.68

0.50

g/l

—

Injury of other and unspecified intrathoracic organs

2.24

2.70

1.1

1.2

—

0.07

g/l

—

Atypical facial pain

2.51

2.70

1.1

1.2

—

0.37

g/l

—

125

2.01

2.70

1.3

1.2

—

0.25

—

Congenital malformations, deformations and chromosomal abnormalities

139

965

1.33

2.68

1.2

0.14

0.32

g/l

—

Dental operations

135

513

1.35

2.68

1.2

0.13

0.26

g/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

198

937

1.27

2.64

1.2

0.09

0.60

g/l

2.58

Crohn disease

191

1.78

2.61

1.1

1.2

—

0.24

g/l

—

Need for other prophylactic measures

2.26

2.60

1.1

1.2

—

0.12

—

Diseases of the ear and mastoid process

255

1034

1.24

2.60

1.2

0.39

0.54

g/l

0.31

Spondylolisthesis/Spondylolysis

214

1.73

2.58

1.2

1.1

—

0.18

g/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

2.19

2.57

1.2

1.1

—

0.04

g/l

—

Hypertensive encephalopathy

7.35

2.57

1.0

—

Injuries to the shoulder and upper arm

173

1088

1.28

2.55

1.2

0.74

0.48

g/l

—

Other shoulder lesions

2.13

2.54

1.1

1.2

—

0.10

g/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

108

769

1.37

2.54

1.2

1.38

0.44

g/l

—

Coronary atherosclerosis

125

589

1.34

2.50

1.2

0.10

0.82

g/l

2.42

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

2.11

2.48

1.3

1.1

—

0.04

g/l

—

Use of amantadine

3.84

2.47

1.0

—

g/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

173

1.80

2.45

1.3

1.2

1.18

0.13

g/l

—

Injuries to the hip and thigh

621

1.39

2.44

1.3

1.2

0.81

0.43

g/l

—

Other disorders of ear

191

991

1.26

2.44

1.2

0.79

0.50

g/l

0.28

Malignant neoplasm of brain, including Hilmo

0.00

2.40

0.0

1.2

—

0.07

—

Demyelinating diseases of the central nervous system

124

1.94

2.40

1.2

1.1

—

0.10

g/l

—

Cholinergic urticaria

6.38

2.38

1.2

1.0

—

g/l

—

Complications peculiar to reattachment and amputation

6.35

2.38

1.2

1.1

—

g/l

—

Perineal laceration during delivery

223

0.41

2.37

1.1

1.2

—

0.19

—

Obesity, other/unspecified

524

1.43

2.36

1.1

1.2

—

0.24

g/l

—

Major coronary heart disease event excluding revascularizations

119

593

1.34

2.36

1.2

0.06

0.82

g/l

—

Other and unspecified glaucoma

2.15

2.34

1.2

—

0.10

g/l

—

Carpal tunnel syndrome

123

822

1.32

2.32

1.2

0.25

0.60

g/l

—

Other disorders of optic [2nd] nerve and visual pathways

2.19

2.31

1.3

1.2

—

0.06

g/l

—

COPD, early/later onset

520

1.39

2.29

1.3

1.2

1.20

0.47

g/l

—

Bronchiectasis

2.07

2.27

1.2

—

0.32

—

Diabetes, insulin treatment (Kela reimbursement)

210

1025

1.24

2.26

1.1

1.2

0.09

0.55

g/l

2.47

COPD, hospital admissions

516

1.39

2.26

1.3

1.2

1.20

0.47

g/l

—

Other disorders of eyelid

575

1.39

2.25

1.2

0.24

0.60

g/l

—

Benign neoplasm of bone and articular cartilage

113

1.95

2.25

1.1

1.2

—

0.25

—

Suggestive for eosinophilic asthma

113

1.95

2.25

1.1

1.2

—

0.26

g/l

—

Nail disorders

107

1.97

2.20

1.0

1.2

—

0.13

—

Intracranial and intraspinal abscess and granuloma

4.33

2.16

1.2

1.1

—

Eosinophilic disease (BM)

3.71

2.15

1.1

—

Abnormal spermatozoa

149

0.33

2.14

1.2

—

0.14

g/l

—

Presence of cardiac and vascular implants and grafts

426

1.40

2.13

1.2

0.12

0.71

g/l

—

Caries of enamel

186

1082

1.24

2.12

1.2

0.79

0.51

g/l

—

Type 2 diabetes, strict (exclude DM1)

196

930

1.24

2.12

1.2

0.20

0.62

g/l

1.59

Polyp of the female genital tract

284

1.44

2.12

1.1

1.2

0.66

0.55

g/l

—

Type 2 diabetes, definitions combined

195

925

1.24

2.12

1.2

0.20

0.63

g/l

1.62

Injuries to the wrist and hand

209

1182

1.23

2.11

1.2

0.09

0.59

g/l

—

Retention of urine

363

1.45

2.11

1.2

0.25

0.13

g/l

—

Myocardial infarction, without ST-elevation

465

1.41

2.11

1.3

1.2

0.05

0.66

g/l

—

Malignant neoplasm of bone and articular cartilage

5.05

2.07

1.2

1.0

—

Nonpyogenic thrombosis of intracranial venous system

4.05

2.04

1.2

1.1

—

Acute pancreatitis

262

1.57

2.02

1.1

1.2

0.21

0.27

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

2.11

2.01

1.1

1.3

—

0.30

—

Synovial cyst of popliteal space [Baker]

2.23

2.00

1.0

1.2

—

0.11

g/l

—

Contact with machinery

146

0.34

2.00

1.0

1.2

—

0.13

—

Other disorders of glucose regulation and pancreatic internal secretion

104

1.93

2.00

1.3

1.2

—

0.06

g/l

—

Glucosamine medication

540

1.35

1.98

1.1

1.2

0.39

0.52

g/l

—

Acute pharyngitis

200

1.64

1.95

1.1

1.2

—

0.15

g/l

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

4.63

1.95

1.0

1.1

—

Autoimmune hepatitis

4.60

1.95

1.0

—

IBD patients in KELA-register

321

1.50

1.94

1.2

—

0.23

g/l

—

Exclusions for E4_PCOS_CONSORTIUM

151

753

1.26

1.92

1.2

0.24

0.43

g/l

—

Congenital malformations, deformations and chromosomal abnormalities

121

901

1.28

1.90

1.2

0.14

0.35

g/l

—

In situ neoplasms

531

1.38

1.90

1.2

0.32

0.26

g/l

—

Hernia

192

1055

1.22

1.90

1.3

1.2

0.67

0.48

g/l

0.19

Bacterial, viral and other infectious agents

128

1.80

1.89

1.3

1.1

—

0.10

g/l

—

Fracture of shoulder and upper arm

523

1.38

1.88

1.2

0.21

0.28

g/l

—

Chondropathies

221

1.59

1.84

1.1

1.2

—

0.22

g/l

—

Seborrhoeic dermatitis

101

1.89

1.80

1.1

1.2

—

0.13

—

Personal history of other diseases and conditions

137

1.75

1.80

1.2

1.1

—

0.12

g/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

123

1.79

1.2

1.3

—

0.22

g/l

—

Herpesviral [herpes simplex] infections

161

1.68

1.77

1.3

1.2

—

0.29

g/l

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

219

0.46

1.76

1.1

1.2

—

0.13

—

Acute pancreatitis (for exclusion)

272

1.51

1.75

1.1

1.2

0.21

0.24

g/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

3.35

1.75

1.0

1.1

—

Cervicocranial syndrome

110

1.82

1.72

1.1

—

0.17

g/l

—

Mixed disorders of conduct and emotions, excluding more controls

3.86

1.71

1.0

1.1

—

g/l

—

Overexertion and strenuous or repetitive movements

140

1.72

1.71

1.2

—

0.24

—

Malignant neoplasm of brain

0.00

1.70

0.0

1.2

—

0.06

—

Inflammatory bowel disease, strict (require KELA)

332

1.45

1.69

1.2

—

0.22

g/l

—

MS-disease / Multiple Sclerosis

104

1.83

1.67

1.2

1.1

—

0.06

g/l

—

Secondary thrombocytopenia

3.19

1.66

1.0

1.1

—

g/l

—

Inflammatory disease of uterus

188

1.60

1.65

1.1

1.2

—

0.37

g/l

—

Mental and behavioural disorders due to alcohol

725

1.29

1.64

1.2

0.20

0.46

g/l

—

Other noninflammatory disorders of vulva and perineum

112

1.79

1.64

1.0

1.1

—

0.03

g/l

—

Use of donepezil

203

0.47

1.63

1.2

—

0.38

g/l

—

Alcohol use disorder, ICD-based

590

1.32

1.62

1.2

0.20

0.50

g/l

—

Tinnitus

335

1.43

1.62

1.1

—

0.18

g/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.62

1.62

1.4

1.1

—

g/l

—

Necrosis of pulp, including avohilmo

116

922

1.26

1.62

1.1

1.2

0.79

0.25

g/l

—

Hypercalcemia

2.15

1.61

1.2

1.3

—

0.42

g/l

—

Paralytic ileus and intestinal obstruction

327

1.44

1.61

1.1

1.2

—

0.29

g/l

—

Exposure to other specified factors

151

1138

1.22

1.59

1.3

1.2

0.13

0.54

g/l

—

Vasomotor and allergic rhinitis

564

1.32

1.59

1.1

1.2

—

0.24

g/l

—

Vitreous haemorrhage

121

1.74

1.58

1.1

1.3

—

0.26

g/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

1.93

1.54

1.1

—

0.21

g/l

—

Anogenital herpesviral [herpes simplex] infection

145

1.66

1.53

1.0

1.2

—

0.06

g/l

—

Type 2 diabetes, definitions combined, including avohilmo

190

929

1.19

1.51

1.2

0.21

0.63

g/l

1.63

Mucosal proctocolitis

185

1.57

1.51

1.2

—

0.13

g/l

—

Haemorrhoids and perianal venous thrombosis

424

1.37

1.50

1.3

1.2

0.86

0.28

g/l

—

Gastric ulcer

217

1.52

1.50

1.2

—

0.23

g/l

—

Early lumbar disc prolapse, operated

123

1.71

1.50

1.1

—

0.24

g/l

—

Allergic rhinitis

455

1.35

1.49

1.1

1.2

—

0.24

g/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

641

1.29

1.47

1.2

0.20

0.48

g/l

—

Other bacterial agents as the cause of diseases classified to other chapters

3.15

1.44

1.0

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

111

1.72

1.39

1.2

1.1

—

0.17

g/l

—

Other orthopaedic follow-up care

1.95

1.38

1.1

—

0.43

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

419

1.29

1.38

1.1

1.2

0.68

0.33

g/l

—

Diabetes medication

209

1060

1.17

1.37

1.1

1.2

0.12

0.57

g/l

2.59

Mature T/NK-cell lymphomas, hilmo

2.96

1.36

1.0

1.1

—

g/l

—

Angina pectoris

103

550

1.25

1.35

1.3

1.2

0.11

0.84

g/l

—

Benign neoplasm of breast

160

1.57

1.31

1.2

1.1

—

0.34

g/l

—

Diseases of male genital organs

376

1.26

1.30

1.2

0.18

0.61

g/l

—

Benign neoplasm: Scapula and long bones of upper limb

2.80

1.29

1.0

1.1

—

Malignant neoplasm of skin

466

1.27

1.28

1.2

0.75

0.33

g/l

—

Artrosis, including avohilmo

173

802

1.18

1.28

1.2

0.40

0.34

g/l

—

Other hearing loss

353

1.36

1.27

1.4

1.2

0.34

0.18

g/l

—

Infective bursitis

2.29

1.27

1.3

1.2

—

0.07

—

Pneumothorax

1.79

1.27

1.0

1.2

—

0.12

—

Hypoglycaemia, other or unspecified

1.79

1.27

1.1

—

0.05

g/l

—

Thyroiditis

1.74

1.25

1.2

1.3

—

0.28

g/l

—

Excessive attrition of teeth

110

904

1.22

1.24

1.2

0.34

0.43

g/l

—

Sequelae of injuries of lower limb

123

1.63

1.23

1.1

1.2

—

0.09

—

Gluteal tendinitis

2.01

1.23

1.0

1.2

—

0.24

g/l

—

Degenerative macular diseases

132

1.59

1.20

1.1

1.2

—

0.49

—

Bacterial, viral and other infectious agents

117

1.63

1.18

1.3

1.1

—

0.10

g/l

—

Dementia in Alzheimer disease

158

0.53

1.17

1.1

1.2

—

0.29

g/l

—

Endometriosis of pelvic peritoneum

221

1.42

1.14

1.0

1.2

—

0.17

g/l

—

Other and unspecified injuries of head

1.75

1.12

1.3

1.2

—

0.30

g/l

—

Leiomyoma of uterus

593

0.81

1.09

1.2

0.27

0.51

g/l

—

Dentofacial anomalies [including malocclusion]

139

950

1.18

1.08

1.2

0.99

0.39

g/l

—

Bitten or struck by other mammals

169

1.48

1.07

1.1

1.2

—

0.27

g/l

—

Heartburn

129

1.55

1.05

1.1

—

0.33

—

Delivery

362

0.77

1.05

1.2

1.3

0.06

0.47

g/l

—

Contact with other sharp object(s)

1.67

1.04

1.3

1.1

—

0.04

g/l

—

Glaucoma

100

715

1.20

1.03

1.2

1.85

0.47

g/l

—

Intestinal adhesions without obstruction

1.64

1.03

1.3

1.2

—

0.11

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

123

1.55

0.99

1.2

1.1

—

0.19

g/l

—

Other sexually transmitted chlamydial diseases

123

1.55

0.99

1.4

1.1

—

0.05

—

Otosclerosis

100

1.60

0.96

1.0

1.3

—

0.24

g/l

—

Basal cell carcinoma, including avohilmo

420

1.23

0.95

1.1

1.2

0.71

0.33

g/l

—

Alzheimer’s disease, strict definition

233

0.67

0.94

1.2

—

0.41

g/l

—

Other diseases of gallbladder

1.78

0.94

1.2

—

0.43

g/l

—

Coxarthrosis, primary

104

743

1.19

0.93

1.2

0.98

0.58

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

200

1.40

0.93

1.0

1.2

—

0.23

g/l

—

Noninflammatory disorders of female genital tract

337

1.22

0.93

1.2

0.39

0.52

g/l

—

Lateral epicondylitis

142

1.48

0.92

1.0

1.2

—

0.14

g/l

—

Basal cell carcinoma

406

1.23

0.90

1.1

1.2

0.71

0.36

g/l

—

Abscess of anal and rectal regions

110

1.55

0.90

1.1

1.2

—

0.10

—

Chronic diseases of tonsils and adenoids

153

842

1.15

0.90

1.1

1.2

0.19

0.53

g/l

—

Disease of hard tissues of teeth, NOS

102

449

1.19

0.89

1.1

0.16

0.27

g/l

—

Other disorders of breast

182

0.60

0.89

1.2

—

0.34

—

L02BA Anti-estrogens

230

0.65

0.88

1.2

1.1

—

0.28

—

Unspecified/other endometriosis

127

1.50

0.88

1.1

1.2

—

0.16

g/l

—

Use of disulfiram, acamprosate or naltrexone

129

0.54

0.88

1.3

1.2

—

0.08

—

Other diseases of biliary tract

111

1.53

0.87

1.2

—

0.34

g/l

—

Coxarthrosis, primary, with hip surgery

640

1.20

0.86

1.2

0.98

0.50

g/l

—

Thyrotoxicosis with toxic multinodular goitre

1.63

0.84

1.2

—

0.36

g/l

—

Other (not insulin) diabetes medications

187

987

1.12

0.81

1.1

1.2

0.13

0.62

g/l

—

Exposure to other and unspecified inanimate mechanical forces

1.55

0.81

1.3

1.2

—

0.06

g/l

—

Hallux rigidus

155

1.42

0.80

1.1

1.2

—

0.19

g/l

—

Other or unspecified ileus, impaction or obstruction

224

1.34

0.79

1.1

—

0.31

g/l

—

Other complications of labour and delivery, not elsewhere classified

161

0.63

0.78

1.0

1.2

—

0.14

g/l

—

Sequelae of injuries of head

1.65

0.75

1.5

1.1

—

0.04

—

Bicipital tendinitis

1.67

0.74

1.0

1.2

—

0.11

g/l

—

Benign neoplasm: Caecum

133

1.43

0.73

1.1

1.3

—

0.24

g/l

—

Congenital malformations of genital organs

132

0.60

0.73

1.3

1.1

—

0.12

g/l

—

Tonsillectomy and adenotomy

111

671

1.15

0.73

1.1

1.2

0.06

0.32

g/l

—

Essential (haemorrhagic) thrombocythaemia

1.61

0.72

1.1

1.3

—

0.07

—

Diplopia

159

1.39

0.72

1.0

1.2

—

0.23

g/l

—

Other and unspecified vascular occlusions

101

1.49

0.70

1.1

1.3

—

0.23

g/l

—

Burns and corrosions of external body surface, specified by site

145

0.62

0.69

1.0

1.2

—

0.10

g/l

—

Macular hole

1.64

0.68

1.1

1.4

—

0.29

—

Childhood asthma (age<16)

126

1.38

0.68

1.1

1.2

—

0.25

g/l

—

Childhood asthma (age<16), excluding more controls

126

1.38

0.68

1.1

1.2

—

0.25

g/l

—

Crohn's disease of small intestine

102

1.47

0.67

1.3

1.1

—

0.10

g/l

—

Hypertrophy of breast in women and men

295

0.75

0.67

1.0

1.2

—

0.19

g/l

—

Endometriosis ASRM stages 1,2

258

1.28

0.66

1.0

1.2

—

0.26

g/l

—

Presence of other devices

293

0.75

0.65

1.0

1.1

—

0.16

—

Burns and corrosions

189

0.69

0.63

1.0

1.2

—

0.22

g/l

—

Early lumbar disc prolapse operation

155

1.36

0.62

1.1

—

0.07

g/l

—

Hypertrophy of breast

257

0.74

0.62

1.0

1.2

—

0.22

g/l

—

Struck by thrown, projected or falling objec

1.55

0.62

1.0

1.2

—

0.06

—

Tularaemia

0.00

0.60

0.0

1.1

—

Ulcerative proctitis

1.48

0.60

1.2

1.1

—

0.04

g/l

—

Other vitreous opacities

1.57

0.60

1.1

1.2

—

0.12

g/l

—

Cellulitis of external ear

0.00

0.60

0.0

1.0

—

Adhesive middle ear disease

0.00

0.60

0.0

1.0

—

Foreign body on external eye

209

0.72

0.59

1.1

1.2

—

0.13

g/l

—

Benign lipomatous neoplasm of other sites/unspecified

115

0.61

0.57

1.1

1.3

—

0.25

—

Alcohol dependence

382

1.20

0.57

1.2

0.20

0.22

g/l

—

Vulvovaginal ulceration/inflammation in other diseases

1.48

0.57

1.1

—

0.19

g/l

—

Colorectal adenocarcinoma

218

0.73

0.56

1.3

1.2

—

0.14

g/l

—

Ulcerative rectosigmoiditis

115

1.39

0.56

1.1

1.2

—

0.12

g/l

—

Biguanides

179

996

1.10

0.55

1.1

1.2

0.14

0.54

g/l

—

Conductive and sensorineural hearing loss

139

847

1.11

0.54

1.2

1.05

0.52

g/l

—

Smoking dependency

124

0.64

0.54

1.0

1.2

—

0.13

g/l

—

Mental and behavioural disorders due to tobacco

125

0.64

0.54

1.0

1.2

—

0.13

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

125

1.36

0.53

1.1

1.2

—

0.21

g/l

—

Medical abortion

115

559

1.12

0.51

1.2

0.50

g/l

—

Stomatitis and related lesions

269

1.23

0.51

1.6

1.2

0.12

0.24

g/l

—

Use of antiglaucoma preparations and miotics

1.41

0.50

1.2

—

0.10

g/l

—

Pedestrian injured in transport accident

1.40

0.48

1.3

1.2

—

0.09

g/l

—

Additional codes for the location of defect, injury or illness

1.45

0.48

1.2

—

0.04

—

Intrahepatic Cholestasis of Pregnancy (ICP)

102

1.37

0.47

1.2

1.1

—

0.13

g/l

—

Alzheimer’s disease (Late onset)

206

0.78

0.47

1.2

—

0.47

g/l

—

Vestibular neuronitis

120

1.33

0.46

1.1

1.3

—

0.24

—

Diseases of inner ear

807

1.11

0.45

1.1

1.2

0.19

0.56

g/l

—

Childhood allergy (age < 16)

144

0.74

0.43

1.2

1.1

—

0.08

g/l

—

Infections of genitourinary tract in pregnancy

139

1.30

0.43

1.1

1.2

—

0.34

—

Hydrocele

139

1.30

0.43

1.4

1.3

—

0.13

g/l

—

Colon adenocarcinoma

129

0.70

0.43

1.4

1.2

—

0.10

g/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.41

0.43

1.1

1.2

—

0.10

g/l

—

Malignant neoplasm of head and neck

0.65

0.42

1.0

1.2

—

0.06

—

Carcinoma in situ of cervix uteri

139

0.72

0.41

1.0

1.1

—

0.13

g/l

—

Gastrojejunal ulcer

0.00

0.41

0.0

1.1

—

Abnormalities of forces of labour

150

0.73

0.41

1.2

1.1

—

0.16

g/l

—

Use of fingolimod

0.00

0.41

0.0

1.0

—

Intentional self-harm by unspecified means

0.00

0.41

0.0

1.1

—

Disorder of thyroid, unspecified

0.00

0.40

0.0

1.0

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.40

0.0

1.0

—

Bronchitis, not specified as acute or chronic

103

0.68

0.39

1.3

1.2

—

0.26

g/l

—

Contact with venomous snakes and lizards

0.00

0.39

0.0

1.1

—

Other and unspecified hydrocephalus

0.00

0.39

0.0

1.1

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

106

0.66

0.39

1.1

1.2

—

0.06

—

Dislocation, sprain and strain of joints and ligaments at neck level

224

1.21

0.38

1.2

—

0.23

g/l

—

Malignant neoplasm of colon, including Hilmo

203

0.79

0.38

1.3

1.2

—

0.14

g/l

—

Outcome of delivery

149

1.20

0.38

1.0

1.1

—

0.08

—

Single delivery by forceps and vacuum extractor

156

0.81

0.37

1.1

1.2

—

0.07

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1.31

0.37

1.1

1.2

—

0.06

g/l

—

Conductive hearing loss, unspecified

107

1.31

0.37

1.1

1.2

—

0.16

g/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

143

1.26

0.36

1.1

1.2

—

0.19

g/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.27

0.36

1.2

—

0.04

—

Sensorineural hearing loss

127

797

1.08

0.36

1.2

0.97

0.53

g/l

—

Persons encountering health services in circumstances related to reproduction

104

642

1.09

0.35

1.3

1.2

0.80

0.19

g/l

—

Solid cancers, helper endpoint

143

784

1.08

0.35

1.2

1.1

0.36

0.26

g/l

0.23

Complications of labour and delivery

584

0.91

0.35

1.2

1.51

0.42

g/l

—

Other disorders of penis

117

1.28

0.35

1.2

—

0.13

—

Parkinson's disease, strict definition

167

0.78

0.34

1.1

1.2

—

0.22

g/l

—

Diseases of middle ear and mastoid

105

791

1.09

0.34

1.3

1.2

0.23

0.26

g/l

—

Assault

200

1.20

0.33

1.2

—

0.10

g/l

—

Benign neoplasm: Transverse colon

136

1.25

0.33

1.2

—

0.21

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

256

1.17

0.33

1.2

—

0.22

g/l

—

Hydrocephalus

0.68

0.33

1.0

1.3

—

0.27

—

Other diseases of stomach and duodenum

0.67

0.33

1.5

1.3

—

0.28

g/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

229

1.18

0.32

1.2

—

0.22

g/l

—

Endovascular or surgical operations to intracerebral aneurysms

1.33

0.32

1.0

1.3

—

0.13

g/l

—

Paralytic strabismus

1.33

0.32

1.0

1.3

—

0.11

g/l

—

Organic, including symptomatic, mental disorders

520

1.09

0.31

1.2

1.25

0.39

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

100

0.70

0.30

1.1

1.2

—

0.06

—

Insulin, fast-acting (human)

212

1.18

0.30

1.4

1.2

0.07

0.12

g/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

101

741

1.08

0.29

1.1

1.2

0.35

0.43

g/l

—

Herpesviral keratitis and keratoconjunctivitis

1.25

0.29

1.1

1.2

—

0.12

g/l

—

Vascular syndromes of brain in cerebrovascular disorders

1.25

0.29

1.0

1.3

—

0.05

—

Crowding of teeth, including avohilmo

0.74

0.29

1.5

1.1

—

0.04

—

Female infertility, cervical, vaginal, other or unspecified origin

266

0.88

0.28

1.0

1.2

—

0.46

g/l

—

Melanocytic naevi of other and unspecified parts of face

1.32

0.28

1.1

1.2

—

0.30

—

Impacted cerumen

129

0.77

0.28

1.1

1.2

—

0.27

—

Other osteochondropathies

1.28

0.28

1.1

1.2

—

0.06

g/l

—

Biomechanical lesions, not elsewhere classified

1.25

0.27

1.0

1.2

—

0.12

—

False labour

287

0.89

0.27

1.2

1.1

—

0.19

g/l

—

Other disorders of cornea

131

1.22

0.27

1.0

1.2

—

0.14

g/l

—

Spontaneous rupture of synovium and tendon

1.30

0.26

1.0

1.2

—

0.11

g/l

—

Parkinson's disease, excluding more controls

124

1.22

0.26

1.1

—

0.06

g/l

—

Postpartum haemorrhage

332

0.89

0.26

1.2

1.1

—

0.17

g/l

—

Tobacco use

1.22

0.25

1.1

1.2

—

0.05

g/l

—

Hydronephrosis

114

1.23

0.25

1.0

1.1

—

0.14

—

Lesion of plantar nerve

1.20

0.25

1.3

—

0.33

g/l

—

Other disorders of amniotic fluid and membranes

197

0.84

0.24

1.2

1.1

—

0.16

g/l

—

Benign neoplasm: Choroid

1.28

0.24

1.1

1.2

—

0.32

—

Hypermetropia

0.74

0.24

1.0

1.2

—

0.10

—

Varicose veins of other sites

0.72

0.24

1.0

1.3

—

0.26

—

Type1 diabetes, definitions combined, early onset

1.28

0.23

1.1

—

0.04

g/l

—

Parkinson's disease, including avohilmo

190

0.84

0.23

1.1

1.2

—

0.24

g/l

—

Postpartum haemorrhage due to retained placenta

147

0.82

0.23

1.2

—

0.25

—

Tuberculosis, IBD comorbidity

1.27

0.22

1.2

1.3

—

0.30

g/l

—

Inguinal or femoral hernia, bilateral

135

0.81

0.22

1.0

1.2

—

0.09

g/l

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.1

—

Neuroendocrine tumor and carcinoma of pancreas

0.00

0.21

0.0

1.0

—

Complex cardiac defects

0.00

0.21

0.0

1.0

—

Meckel's diverticulum

0.00

0.21

0.0

1.0

—

Benign neoplasm: Orbit, unspecified

0.00

0.21

0.0

1.0

—

Common variable immunodeficiency

0.00

0.21

0.0

1.1

—

Pediculosis and phthiriasis

0.00

0.21

0.0

1.0

—

Contact with blunt object, undetermined intent

0.00

0.21

0.0

1.0

—

Increased muscle tone

0.00

0.21

0.0

1.1

—

Degenerative myopia

0.00

0.21

0.0

1.1

—

Other and unspecified primary disorders of muscles

0.00

0.21

0.0

1.1

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.0

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.21

0.0

1.0

—

Sequelae of poliomyelitis

0.00

0.21

0.0

1.1

—

Sequelae of poliomyelitis

0.00

0.21

0.0

1.1

—

Tic and related disorders

0.00

0.21

0.0

1.0

—

Tic and related disorders

0.00

0.21

0.0

1.1

—

Vascular dementia (multiple infarctions)

0.00

0.21

0.0

1.0

—

Dislocation of lens

0.00

0.21

0.0

1.0

—

Effects of heat and light

0.00

0.21

0.0

1.1

—

Carcinoma in situ of rectum

0.00

0.21

0.0

1.0

—

Fall on and from ladder

1.23

0.21

1.0

1.2

—

0.10

g/l

—

Persistent delusional disorders

103

0.78

0.21

1.1

1.2

—

0.30

—

Short stature, not elsewhere classified

0.00

0.21

0.0

1.2

—

Other obstructed labour

105

0.76

0.21

1.1

—

0.21

—

Mixed specific developmental disorders

0.00

0.21

0.0

1.1

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.21

0.0

1.1

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

Endometriosis of fallopian tube

0.00

0.21

0.0

1.1

—

Respiratory tuberculosis, clinically confirmed

0.00

0.21

0.0

1.1

—

Other infective otitis externa

1.25

0.20

1.0

1.2

—

0.06

—

Amoebiasis

0.00

0.20

0.0

1.1

—

Other congenital malformations of intestine

0.00

0.20

0.0

1.1

—

Lung diseases due to external agents

164

1.16

0.20

1.0

1.2

—

0.21

g/l

—

Ulcerative colitis (strict definition, require KELA)

240

1.13

0.20

1.2

—

0.22

g/l

—

Oesophageal obstruction

1.20

0.19

1.2

1.3

—

0.11

—

Divergent concomitant strabismus

1.21

0.19

1.2

—

0.10

—

Superficial injury of forearm

127

1.18

0.19

1.1

1.2

—

0.13

g/l

—

Special screening examination for other diseases and disorders

127

1.18

0.19

1.0

1.1

—

0.22

g/l

—

Inguinal hernia, bilateral

133

0.83

0.19

1.0

1.2

—

0.09

g/l

—

Other and unspecified abdominal hernia

1.15

0.19

1.0

1.2

—

0.11

g/l

—

Chronic laryngitis and laryngotracheitis

165

1.15

0.19

1.1

1.2

—

0.25

—

Other appendicitis

118

1.19

0.19

1.1

1.2

—

0.12

g/l

—

Unspecified lump in breast

223

1.12

0.18

1.0

1.1

—

0.28

—

Other noninflammatory disorders of uterus, except cervix

215

1.10

0.17

1.6

1.2

0.49

0.70

g/l

—

Calculus of lower urinary tract

0.75

0.17

1.0

1.3

—

0.07

—

Malignant neoplasm of stomach, including Hilmo

0.75

0.17

1.2

—

0.06

g/l

—

Ptosis of eyelid

129

1.16

0.17

1.1

1.2

—

0.28

—

Malignant neoplasm of pancreas

0.71

0.16

1.2

1.3

—

0.06

—

Antepartum haemorrhage, not elsewhere classified

120

0.83

0.16

1.3

1.1

—

0.09

—

Nasal polyp

263

1.10

0.16

1.1

1.2

—

0.25

g/l

—

Postpartum hemorraghe, all women as controls

375

0.92

0.16

1.2

—

0.23

g/l

—

Suppurative and necrotic conditions of lower respiratory tract

1.14

0.16

1.0

1.2

—

0.06

—

Caught, crushed, jammed or pinched in or between objects

1.10

0.15

1.1

1.2

—

0.04

g/l

—

Parkinson's disease

182

0.88

0.15

1.1

1.2

—

0.23

g/l

—

Multiple delivery

140

1.14

0.15

1.0

1.2

—

0.38

—

Perforation of tympanic membrane

129

0.85

0.14

1.2

—

0.26

g/l

—

Foreign body or object entering through skin

0.79

0.14

1.0

1.2

—

0.06

g/l

—

Lichen sclerosus et atrophicus

1.18

0.14

1.1

—

0.13

g/l

—

Mixed conductive and sensorineural hearing loss

150

1.13

0.14

1.2

1.1

—

0.16

—

Malignant neoplasm of colon

160

0.87

0.14

1.4

1.2

—

0.10

g/l

—

FESS (DNB20)

179

1.12

0.14

1.2

—

0.24

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.82

0.13

1.3

1.2

—

0.10

g/l

—

Chronic suppurative otitis media, including avohilmo

0.82

0.13

1.0

1.3

—

0.09

—

Familial hypercholesterolemia, with ischemic heart disease

0.82

0.13

1.3

1.2

—

0.68

—

Foreign body entering into or through eye or natural orifice

109

0.83

0.13

1.1

1.2

—

0.07

g/l

—

Normotensive glaucoma

104

1.15

0.12

1.1

1.2

—

0.10

g/l

—

Anogenital herpesviral [herpes simplex] infection

1.18

0.12

1.1

—

0.05

g/l

—

Colorectal cancer

256

0.92

0.12

1.3

1.2

—

0.12

g/l

—

Glucagon-like peptide-1 (GLP-1) analogues

416

0.94

0.12

1.2

0.08

0.26

g/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

416

0.94

0.12

1.2

0.08

0.26

g/l

—

Ethmoidectomy

191

1.10

0.11

1.1

1.2

—

0.23

g/l

—

Other abnormal products of conception

333

1.05

0.11

1.0

1.2

—

0.38

g/l

—

Tuberculosis, wide

1.16

0.11

1.2

1.3

—

0.27

g/l

—

Effects of foreign body entering through natural orifice

362

0.94

0.10

1.1

1.2

—

0.21

g/l

—

LSIL lesion of the cervix uteri

156

0.90

0.10

1.2

1.1

—

0.19

g/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

1.09

0.09

1.0

1.2

—

0.11

—

Postpartum haemorrhage due to anatomy

114

0.88

0.09

1.3

—

0.30

g/l

—

Complications following abortion and ectopic and molar pregnancy

1.06

0.09

1.0

1.3

—

0.44

g/l

—

Paralytic ileus

1.04

0.09

1.0

1.2

—

0.07

—

Follicular lymphoma, hilmo

1.09

0.09

1.0

1.4

—

0.37

—

Respiratory tuberculosis, confirmed and not-confirmed

1.07

0.08

1.2

1.3

—

0.07

g/l

—

Respiratory tuberculosis

1.07

0.08

1.2

1.3

—

0.07

g/l

—

Pyothorax

1.05

0.08

1.0

1.3

—

0.06

—

Urethral stricture

0.83

0.08

1.0

1.2

—

0.08

g/l

—

Tuberculosis

1.09

0.08

1.1

1.3

—

0.11

g/l

—

Malignant neoplasm of rectum, including Hilmo

133

0.90

0.07

1.2

—

0.09

—

Acute gastritis

1.12

0.07

1.0

1.2

—

0.24

—

Right hemicolectomy

0.83

0.07

1.2

1.3

—

0.11

g/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

1.05

0.07

1.4

1.3

—

0.37

—

Other ulcerative colitis

1.04

0.07

1.1

—

0.04

—

Parkinson's disease, strict definition, excluding more controls

112

1.11

0.07

1.1

—

0.06

g/l

—

Fitting and adjustment of other devices

416

1.04

0.07

1.1

1.2

—

0.48

g/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

108

1.11

0.07

1.1

1.3

—

0.10

g/l

—

Pleural plaque with presence of asbestos

1.03

0.07

1.0

1.2

—

0.07

—

Chronic suppurative otitis media

0.83

0.07

1.0

1.2

—

0.10

—

Tongue abnormality

1.07

0.07

1.0

1.3

—

0.33

g/l

—

Artificial joint re-operation

1.02

0.07

1.0

1.3

—

0.26

—

Spermatocele

0.89

0.06

1.0

1.3

—

0.13

—

Other contact dermatitis

0.89

0.06

1.1

1.2

—

0.16

—

L02BB Anti-androgens

0.87

0.06

1.1

1.2

—

0.08

g/l

—

Myocardial infarction, with ST-elevation

216

1.06

0.06

1.0

1.2

—

0.26

g/l

—

Presbyopia

0.84

0.06

1.0

1.1

—

0.22

g/l

—

Type 1 diabetes, strict definition, subgroup 1

1.11

0.06

1.1

—

0.08

g/l

—

Assault by bodily force

109

1.10

0.06

1.1

—

0.04

—

Inguinal hernia

614

1.02

0.06

1.2

0.07

0.51

g/l

—

Vasomotor rhinitis (mode)

100

1.10

0.05

1.4

1.2

—

0.25

g/l

—

Disorders of psychological development

121

0.92

0.05

1.0

1.2

—

0.07

g/l

—

Hyperplasia of prostate

270

1.03

0.04

1.2

1.3

0.23

0.75

g/l

—

Other peripheral vertigo

119

0.92

0.04

1.3

—

0.24

g/l

—

LSIL lesion of the cervix uteri, vagina or vulva

200

0.95

0.03

1.2

—

0.31

g/l

—

Use of levodopa decarboxylase inhibitor

158

0.95

0.02

1.1

1.2

—

0.23

g/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

208

0.96

0.02

1.2

—

0.21

g/l

—

Pregnancy examination and test

150

1.04

0.02

1.0

1.1

—

0.08

g/l

—

Polypectomy (DHB20)

1.06

0.01

1.1

1.2

—

0.07

g/l

—

Pneumonitis due to solids and liquids

1.06

0.01

1.0

1.2

—

0.07

—

Otitis externa, unspecified

164

1.04

0.00

1.1

1.2

—

0.25

g/l

—

Supervision of normal pregnancy

179

1.02

0.00

1.1

—

0.11

g/l

—

Other blood glucose lowering drugs, excl. Insulins

224

1.03

0.00

1.1

1.2

—

0.40

g/l

—

Postpartum hemorraghe, parous women as controls

296

1.01

0.00

1.2

—

0.43

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

122

0.98

0.00

1.2

—

0.39

g/l

—

Pedal cyclist injured in other and unspecified transport accidents

152

0.99

0.00

1.1

1.2

—

0.20

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

115

1.04

0.00

1.1

1.3

—

0.26

g/l

—

Lichen planus

155

0.97

0.00

1.2

—

0.31

g/l

—

Malignant neoplasm of rectum

104

0.96

0.00

1.2

—

0.06

—

Alzheimer’s disease (Late onset), excluding more controls

0.99

0.00

1.2

1.1

—

0.75

g/l

—

Retained placenta and membranes, without haemorrhage

163

0.98

0.00

1.1

1.2

—

0.31

g/l

—

Coronary artery bypass grafting

240

0.99

0.00

1.2

1.3

0.10

1.17

g/l

—

Type 1 diabetes, strict definition

107

1.03

0.00

1.1

—

0.08

g/l

—

Pollen allergy

254

1.01

0.00

1.1

1.2

—

0.14

—

Other specified transport accidents

0.00

0.0

1.1

—

Idiopathic hypoparathyroidism

0.00

0.0

1.2

—

Malignant neoplasm of nasal cavity and middle ear

0.00

0.0

1.0

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.0

1.0

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.2

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.2

—

Fibrosarcoma

0.00

0.0

1.0

—

Effects of air pressure and water pressure

0.00

0.0

1.0

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.0

—

Syndactyly

0.00

0.0

1.0

—

0.00

0.0

1.1

—

Effects of other deprivation

0.00

0.0

1.0

—

Nezelof syndrome

0.00

0.0

1.0

—

Reduction defects of upper limb

0.00

0.0

1.0

—

Congenital lens malformations

0.00

0.0

1.0

—

Maxillary hypoplasia

0.00

0.0

1.0

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

0.0

1.0

—

Fall involving playground equipment

0.00

0.0

1.0

—

Impotence

0.94

0.00

1.3

1.2

—

0.06

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.0

1.0

—

Radiodermatitis

0.00

0.0

1.2

—

Diphtheria

0.00

0.0

1.0

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.0

1.1

—

Superficial injury of ankle and foot, unspecified

0.00

0.0

1.0

—

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

Right ventricular outflow tract obstruction

0.00

0.0

1.0

—

Actinomycosis

0.00

0.0

1.0

—

Atrioventricular septal defect

0.00

0.0

1.0

—

Other leukaemias of specified cell type

0.00

0.0

1.0

—

Reduction defects of upper limb

0.00

0.0

1.0

—

Other disorders of amino-acid metabolism

0.00

0.0

1.1

—

Pectus excavatum

0.00

0.0

1.0

—

Other and unspecified myoneural disorders

0.00

-0.00

0.0

1.1

—

Ovarian dysfunction: androgen excess

0.00

-0.00

0.0

1.0

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.0

—

Precocious puberty

0.00

-0.00

0.0

1.0

—

Familial erythrocytosis

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.0

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

-0.00

0.0

1.2

—

Carcinoma in situ of vagina

0.00

-0.00

0.0

1.1

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.0

—

Monoarthritis, not elsewhere classified

1.02

-0.00

1.2

1.1

—

0.17

g/l

—

Benign neoplasm: Vertebral column

0.00

-0.00

0.0

1.0

—

Disorders of male genital organs in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

-0.00

0.0

1.2

—

Residual foreign body in soft tissue

0.98

-0.00

1.2

—

0.06

—

Benign neoplasm: Brain, infratentorial

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.0

—

Follicular adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

-0.00

0.0

1.2

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

-0.00

0.0

1.0

—

Labyrinthine fistula

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.0

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

-0.00

0.0

1.0

—

Complications of anaesthesia during pregnancy

0.00

-0.00

0.0

1.0

—

Intentional self-harm by hanging, strangulation and suffocation

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Brain, unspecified

0.00

-0.00

0.0

1.1

—

Malignant neoplasm, without specification of site, including Hilmo

0.98

-0.00

1.0

1.3

—

0.06

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Floor of mouth

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of nasal cavity and sinuses

0.00

-0.00

0.0

1.0

—

Seminoma of testis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of stomach

1.00

-0.00

1.2

1.3

—

0.07

g/l

—

Malignant neoplasm of nasopharynx, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of oral cavity, including Hilmo

0.98

-0.00

1.0

1.2

—

0.07

—

Brain astrocytoma

0.00

-0.00

0.0

1.0

—

Hereditary factor VIII deficiency

0.00

-0.00

0.0

1.0

—

Thalassaemia

0.00

-0.00

0.0

1.0

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

1.0

—

Contact urticaria

0.00

-0.00

0.0

1.0

—

Changes in corneal membranes

0.00

-0.00

0.0

1.0

—

Findings of drugs and other substances, not normally found in blood

0.00

-0.00

0.0

1.0

—

Pleural plaque

0.98

-0.00

1.0

1.2

—

0.16

—

Other and unspecified disorders of autonomic nervous system

0.00

-0.00

0.0

1.0

—

Cholesteatoma of external ear

0.00

-0.00

0.0

1.1

—

Squamous cell neoplasms and carcinoma of cervix

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Mediastinum

0.00

-0.00

0.0

1.0

—

Mucinous and mucinous cystic tumor of rectum

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Other or unspecified common variable immunodeficiency

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

-0.00

0.0

1.1

—

Surgical ablation of atrial fibrillation

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of floor of mouth

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

-0.00

0.0

1.0

—

Epileptic seizures related to alcohol

0.00

-0.00

0.0

1.0

—

Other adrenocortical overactivity

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

1.0

—

Typhoid and paratyphoid fevers

0.00

-0.00

0.0

1.1

—

Marasmic kwashiorkor

0.00

-0.00

0.0

1.2

—

Adenocarcinomas of cervix

0.00

-0.00

0.0

1.0

—

Other and unspecified heterotropia

0.00

-0.00

0.0

1.0

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

-0.00

0.0

1.0

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

0.00

-0.00

0.0

1.0

—

Other cestode infections

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of accessory sinuses

0.00

-0.00

0.0

1.0

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.0

—

Congenital cataract

0.00

-0.00

0.0

1.0

—

Other chromosome abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other hypertrichosis

0.00

-0.00

0.0

1.0

—

Other congenital malformations of tongue, mouth and pharynx

0.00

-0.00

0.0

1.0

—

Carcinoid syndrome

0.00

-0.00

0.0

1.1

—

Other congenital malformations of intestine

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

-0.00

0.0

1.0

—

Other helminthiases

0.00

-0.00

0.0

1.0

—

Frontotemporal dementia

0.00

-0.00

0.0

1.1

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.0

—

Sequelae of infectious and parasitic diseases

0.97

-0.00

1.0

1.1

—

0.10

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

-0.00

0.0

1.0

—

Amoebiasis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thymus

0.00

-0.00

0.0

1.0

—

Severe visual impairment, binocular

0.00

-0.00

0.0

1.2

—

Complications of anaesthesia during labour and delivery

0.00

-0.00

0.0

1.0

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thymus, including Hilmo

0.00

-0.00

0.0

1.0

—

Rhinophyma

0.00

-0.00

0.0

1.0

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

-0.00

0.0

1.0

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.0

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

1.0

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.0

—

Cleft lip

0.00

-0.00

0.0

1.0

—

Use of entacapone

0.00

-0.00

0.0

1.1

—

Feeding problems of newborn

0.00

-0.00

0.0

1.0

—

Complications of anaesthesia during the puerperium

0.00

-0.00

0.0

1.0

—

Congenital stenosis of pulmonary valve

0.00

-0.00

0.0

1.0

—

Laparoscopic right hemicolectomy

0.92

-0.00

1.7

1.3

—

0.27

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1.01

-0.00

1.1

—

0.23

g/l

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.0

—

Reduction defects of lower limb

0.00

-0.00

0.0

1.0

—

Congenital vesicoureteral reflux

0.00

-0.00

0.0

1.0

—

Reduction defects of lower limb

0.00

-0.00

0.0

1.0

—

Complications specific to multiple gestation

0.00

-0.00

0.0

1.0

—

Isolated patent ductus arteriosus

0.00

-0.00

0.0

1.0

—

Epidermolysis bullosa

0.00

-0.00

0.0

1.0

—

Syndactyly

0.00

-0.00

0.0

1.0

—

Pectus excavatum

0.00

-0.00

0.0

1.0

—

Degenerative macular diseases, drug-induced

0.00

-0.00

0.0

1.2

—

Use of peginterferon beta-1a

0.00

-0.00

0.0

1.0

—

Unicornuate uterus

0.00

-0.00

0.0

1.0

—

Muscle wasting and atrophy, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Endometriosis in cutaneous scar

0.00

-0.00

0.0

1.2

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Hypertrophy of bone

0.00

-0.00

0.0

1.0

—

Anuria and oliguria

0.00

-0.00

0.0

1.0

—

Spina bifida

0.00

-0.00

0.0

1.0

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.0

—

Lichen planopilaris

0.00

-0.00

0.0

1.0

—

Delayed milestone in childhood

0.00

-0.00

0.0

1.1

—

Unattended death

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.0

—

Acne conglobata

0.00

-0.00

0.0

1.0

—

Perforation of oesophagus

0.00

-0.00

0.0

1.2

—

Osteitis due to dental implant

0.00

-0.00

0.0

1.1

—

Open wounds involving multiple body regions

0.00

-0.00

0.0

1.0

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.0

—

Other superficial injuries of ankle and foot

0.00

-0.00

0.0

1.0

—

Injury of nerves at hip and thigh level

0.00

-0.00

0.0

1.2

—

Toxic effect of corrosive substances

0.00

-0.00

0.0

1.0

—

Toxic effect of organic solvents

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified effects of external causes

0.00

-0.00

0.0

1.0

—

Toxic effect of other gases, fumes and vapours

0.00

-0.00

0.0

1.0

—

Unspecified multiple injuries

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (undefined), excluding more controls

0.00

-0.00

0.0

1.2

—

Other disorders of carbohydrate metabolism

0.00

-0.00

0.0

1.0

—

Assault by hanging, strangulation and suffocation

0.00

-0.00

0.0

1.0

—

Contact with heat and hot substances

0.91

-0.00

1.0

1.2

—

0.04

g/l

—

Exposure to ignition of highly flammable material

0.00

-0.00

0.0

1.2

—

Other and unspecified disorders of psychological development

0.00

-0.00

0.0

1.0

—

Vascular dementia

0.92

-0.00

1.1

1.3

—

0.44

g/l

—

Other endophthalmitis

0.00

-0.00

0.0

1.1

—

Other proliferative retinopathy

0.00

-0.00

0.0

1.0

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Exposure to uncontrolled fire in building or structure

0.00

-0.00

0.0

1.0

—

Labyrinthitis

0.00

-0.00

0.0

1.0

—

Neuroendocrine tumor and carcinoma of lung

0.00

-0.00

0.0

1.0

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.0

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

0.00

-0.00

0.0

1.1

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.0

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.0

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.0

—

Convalescence

0.91

-0.00

1.2

—

0.42

g/l

—

Enduring personality changes

0.00

-0.00

0.0

1.0

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.0

—

Acute thyroiditis

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cryoglobulin [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS